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ABSTRACT OF DISSERTATION

GENETIC REGULATION OF HEMATOPOIETIC STEM CELL AGING
It is well documented that both quantitative and qualitative changes in the murine
hematopoietic stem cell (HSC) population occur with age. In mice, the effect of aging on
stem cells is highly strain-specific, thus suggesting genetic regulation plays a role in HSC
aging. In C57BL/6 (B6) mice, the HSC population steadily increases with age, whereas in
DBA/2 (D2) mice, this population declines. Our lab has previously mapped a
quantitative trait locus (QTL) to murine chromosome 2 that is associated with the
variation in frequency of HSCs between aged B6 and D2 mice. In these dissertation
studies, I first aim to characterize the congenic mouse model which was generated by
introgressing D2 alleles in the QTL onto a B6 background. Using a surrogate assay to
mimic aging, I analyzed the cell cycle, apoptotic and self-renewal capabilities of
congenic and B6 HSCs and show that D2 alleles in the QTL affect the apoptotic and selfrenewal capabilities of HSCs. In the second aim of these studies, I used oligonucleotide
arrays to compare the differential expression of B6 and congenic cells using a population
enriched for primitive stem and progenitor cells. Extensive analysis of the expression
arrays pointed to two strong candidates, the genes encoding Retinoblastoma like protein 1
(p107) and Sorting nexin 5 (Snx5). B6 alleles were associated with increased p107 and
Snx5 expression in old HSCs therefore both genes were hypothesized to be positive
regulators of stem cell number in aged mice. Finally, in the third aim of these studies, I
show that the individual overexpression of p107 and Snx5 in congeic HSCs increases
day35 cobblestone area forming cell (CAFC) numbers, therefore confirming their roles as
positive regulators of HSC number in vitro. These studies uncover novel roles for p107
and Snx5 in the regulation of HSC numbers and provide additional clues in the complex
regulation of HSC aging.
KEYWORDS: Hematopoietic Stem Cells, Aging, Genetic Regulation, QTL analysis,
DNA damage.
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CHAPTER ONE
Introduction
Properties of Hematopoietic Stem Cells and Organization of the HSC Hierarchy
Hematopoietic stem cells (HSCs) are described conceptually as pluripotent cells
with the potential to generate all of the mature blood cells in the body over the lifetime of
an organism. In the early 1960s, Siminovitch et al. provided what remain today the two
functional criteria for defining HSCs: the capacity for multi-lineage differentiation and
the ability to self-renew to give rise to more HSCs (Siminovitch et al., 1963; Till and
Mccullough, 1961). Adult hematopoietic stem cells comprise approximately 0.01% of the
bone marrow compartment in which they reside, yet they are responsible for the
continuous replenishment of mature blood cells lost through attrition and routine somatic
cell aging (Geiger and Van Zant, 2002). A delicate balance between self-renewal,
differentiation, and cell death must be maintained to ensure not only hematopoietic
homeostasis, but also organismal homeostasis and longevity.
Mouse HSC populations have been subdivided into three populations 1) long-term
HSCs (LT-HSCs), which have extensive self-renewal capacity, 2) short-term HSCs (STHSCs), which have a limited self-renewal capacity, and 3) multipotent progenitor cells,
which do not self-renew and ultimately differentiate into either myeloid or lymphoid
precursor cells (Figure 1.1). Thus the differences in developmental potential and the
linear relationship of stem and progenitor cells represent a well-established biological
hierarchy. LT-HSCs possess high proliferation potential and can generate all eight
mature hematopoietic lineages: B and T lymphocytes, erythrocytes,
megakaryocytes/platelets, basophils/mast cells, eosinophils, neutrophils, and
monocytes/macrophages (Szilvassy, 2003). In mice, a single LT-HSC can regenerate and
maintain the hematopoietic system of an irradiated host, demonstrating the extensive
proliferation and long-term multi-lineage reconstituting activity of this primitive cell
population (Osawa et al., 1996). Multipotent progenitor cells give rise to clonogenic
cells that are able to differentiate into cells of a single hematopoietic lineage (Abramson
et al., 1977). Common lymphoid progenitors possess a lymphoid-restricted capacity and
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produce B and T cells and natural killer cells (Kondo et al., 1997), while common
myeloid progenitors give rise to megakaryocyte/erythrocyte or granulocyte/macrophage
cells (Akashi et al., 2000). A small reserve of HSCs carry the burden of replenishing
millions of mature cells daily throughout the lifetime of an individual in order to prevent
immunosenescence or aplasia. There is no compelling evidence that stem cell reserves
decline sufficiently in old age to threaten adequate blood cell production (Rando, 2006).
However, studies do indicate that aged tissues have a diminished capacity to return to a
homeostatic state after exposure to stress or injury, therefore indicating a defect in stem
cell function during the aging process. Since the HSC population provides an ideal
model to study stem cell aging, it is necessary to elucidate the mechanisms of
hematopoietic aging and expand the findings to other tissues and organ systems.
Theories of Aging and Age Related Epigenomic Changes
There are two major theories of organismal aging: evolutionary and damage
based. The former suggests that natural selection favors a genetic composition that
enhances reproductive fitness and fecundity. According to the theory, since the effect of
this genetic repertoire on vitality following the reproductive lifespan is immaterial to the
propagation of the species, genes have been selected and accumulated which favor
reproductive success but have negative effects later in life, thus limiting lifespan. Simply
put, aging genes have not been selected based on their value for fitness, but are most
likely by-products of evolution (Vijg and Suh, 2005). This idea has been termed
antagonistic pleiotrophy, and can be used to explain how genetic traits can have both
beneficial and deleterious effects for a species (Campisi, 1997). Campisi and others
propose that cellular senescence, for example, is antagonistically pleiotropic, suggesting
that the senescence response is a selected phenotype that prevents cancer during early
life, while at later times contributes to age related pathologies (Campisi, 1997; Krtolica
and Campisi, 2002). The second theory of aging argues that accumulated cellular damage
over a lifetime limits the effective functioning of key organ systems. Poorly repaired
damage of chromosomal DNA, stress-related aberrations in structural enzymes or protein
turnover, and/or deletions in mitochondrial DNA, for example, may compromise organ
function and in turn limit longevity. Given the extremely complex phenotype of aging,
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numerous other theories such as the free radial theory of aging (Harman, 1956) and
protein damage accumulation theory (Levine, 2002) have been postulated in an attempt to
explain what aging is and why it happens. A common theme among many of these
theories is to take a reductionist approach and focus attention at the molecular level in
hopes of understanding the aging of organisms through the aging of their components. In
our quest to understand the aging process, we must face reality and succumb to the notion
that aging is a multifactorial process; therefore it’s likely that all of the aforementioned
processes factor into this phenomenon.
An important theme emerging in the field of aging research is the role of
epigenetic alterations in aging mammalian tissues. As mentioned above, genetic
instability in the form of direct DNA mutations, translocations, and/or deletions has been
proposed to accumulate with age. However, studies reveal that there is yet another class
of heritable DNA alterations that are not associated with direct changes in primary
nucleotide sequences. These epigenetic changes can alter gene expression patterns
simply by treating the same sequence of DNA differently at the level of the individual,
organ, cell lineage or even differentiation state (Mager and Bartolomei, 2005).
Epigenetic modifications, most commonly in the form of changes in the methylation
status of DNA and biochemical modifications of core histones, have been linked to the
aging process and are increasingly recognized as part of normal and pathologic aging
physiology (Issa, 2003). Manel Esteller’s group studied the epigenetic profiles of 80
pairs of monozygotic twins ranging in age from 3-74 years old and found that older twins
exhibited large differences in their overall content and distribution of 5-methylcytosine
DNA and histone acetylation compared to young twins which were largely
indistinguishable epigenetically (Fraga et al., 2005). The epigenetic changes that
accumulated with age had a dramatic effect on gene expression, thus the authors propose
that a so-called “epigenetic drift” accompanies the aging process. Epigenetic
modifications can result in the cumulative loss of gene regulation over time, ultimately
impairing cellular and tissue function. Further, recent data suggest that epigenetic
disruption of tissue specific stem and progenitor cells may play a role in cancer
development (Feinberg et al., 2006). The correlation between aging and loss of

3

epigenetic control is consistent with the established connection between aging and cancer
(Figure 1.2).
HSCs as a Model for Stem Cell Aging
When studying aging it is important to choose an appropriate model system. For
instance, cells (such as skin and blood) that undergo continuous turnover are removed
from circulation long before they have time to feel the effects of aging, and certainly long
before they could exert an effect on tissue function. The predominant substrates for
aging, thus it seems, would be long-lived cells in the organism, namely tissue specific
stem cells, since this population is exposed to both intrinsic and extrinsic effectors of
aging throughout the lifespan of an individual. Within the last several years, stem cells
have been discovered in a growing list of adult tissues. There is new-found appreciation
that cell turnover and tissue replacement are not the sole province of the hematopoietic
system, the gut lining, and the skin as had been the dogma for many years (Potten and
Loeffler, 1990). The limited lifespan of somatic cells implies that a constant replacement
of aged cells must occur in order for any tissue to maintain its optimal function. With
this in mind, it has been hypothesized that the aging or functional failure of tissuespecific stem cells, which fulfill this job, may limit tissue repair and renewal, therefore
contributing to overall organismal aging (Krtolica, 2005; Van Zant and Liang, 2003).
Because of the unprecedented experimental model systems that are available for the
exploration of HSCs, stem cell aging research in the field of hematology has been the
subject of extensive studies. Indeed, the hematopoietic system has served as an important
model for advancing our understanding of stem cell biology and its association with
aging. It is likely that the same broad concepts that define and characterize bloodforming stem cells will apply to stem cell populations found elsewhere. In view of the
importance of HSCs for maintaining immune function (preventing immunosenescence)
and in a broader sense tissue homeostasis and longevity, there is a critical need to better
understand the mechanisms involved not only in HSC aging, but aging in other stem cell
compartments as well.
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Evidence for HSC Aging
Despite their ability to self-renew and maintain steady-state hematopoietic
function in aged mice and humans, a close examination of the available data shows that
age-related changes in the HSC population do occur, ultimately resulting in a decline in
stem cell function (Harrison, 1972; Rothstein, 1993). For example, when testing HSC
function in vivo using competitive repopulation experiments in which the repopulating
ability of HSCs is tested in irradiated recipients, adult bone marrow has a decreased
ability to repopulate myeloablated recipient mice compared to fetal liver (Harrison et al.,
1997). Also, Kim et al. observed a defect in B-cell engraftment and a differentiation
pattern skewed toward the myeloid lineage in recipients of transplants from old HSC
donors compared to young donors (Kim et al., 2003). In agreement with this finding,
microarray analyses comparing the gene expression profile of young and old HSCs
showed a marked upregulation of myeloid-associated genes and downregulation of
lymphoid genes with age (Rossi et al., 2005). Indeed the increased propensity of HSCs
to produce myeloid cells with age may be involved in the increase in myeloproliferative
diseases seen in the elderly (Warren and Rossi, 2008). Further, HSCs from old mice are
less efficient at homing to and engrafting in the bone marrow of young irradiated
recipients (Liang et al., 2005; Morrison et al., 1996). Additional evidence suggests that
the proliferative response of murine HSCs to early acting cytokines also declines with
age (Henckaerts et al., 2004). Similar results have been observed in human HSCs, in that
a progressive decline in function as well as HSC number occurs with increasing age
(Figure 1.3) (Lansdorp et al., 1994).
Recent evidence suggests that DNA damage accumulation contributes
significantly to the decline in stem cell function with age (Nijnik et al., 2007; Rossi et al.,
2007). Rossi et al. examined hematopoietic stem cell function with age in mice deficient
in various genomic maintenance pathways, and showed that, although HSC reserves were
not depleted with age, stem cell functional capacity was severely compromised under
conditions of stress in old versus young cells. They hypothesized that the accumulation
of DNA damage in HSCs during aging may be limiting the function of these cells in
response to injury. In accordance with their hypothesis, they showed that 82% LT-HSCs
from old wild-type mice stained positively for γ- H2AX (an indicator of DNA double-
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stranded breaks), while young LT-HSCs were largely devoid of the damage marker
(Rossi et al., 2007).
Epigenetic alterations have also been implicated in HSC aging (Chambers et al.,
2007b; Rossi et al., 2005). Chambers et al. performed microarray analyses on highly
purified HSCs from mice aged 2 to 21 months and found a remarkable downregulation of
genes involved in chromatin remodeling and DNA repair. Genes involved in
transcriptional silencing via chromatin remodeling (Smarca4 and Amarcb1) as well as
histone deacetylases (Hdac1, -5, and -6) and a DNA methyltransferace (Dnmt3b) were
downregulated in aged cells. They also showed that several chromosomal regions
changed with age in a coordinated manner resulting in an overall increase in
transcriptional activity. They propose that chromatin dysregulation and epigenetic
changes drive the loss of cellular function and ultimately drive the aging process in
HSCs. Consistent with these data, Polycomb proteins (transcriptional repressors), such as
Ezh2 and Bmi-1, have been shown to influence self-renewal and cell fate determination
decisions in HSCs (Lessard et al., 1998; Park et al., 2003). Ezh2 and Bmi-1 act as
transcriptional repressors that stabilize the self-renewing HSC population, thus
downregulation of these genes with age would likely compromise the functional quality
of the HSC pool.
Another mechanism contributing to the functional failure of HSCs is cellular
senescence, a process that results in the irreversible loss of cell division. Many stimuli
have been shown to induce the senescence response including, but not limited to,
telomere erosion, certain types of DNA damage, such as DNA breaks and oxidative
lesions, epigenetic changes to chromatin organization, as well as exposure to ionizing
irradiation (Campisi, 2005; Wang et al., 2006). There is increasing evidence that
senescent cells accumulate with age. Senescence-associated β-galactosidase, an enzyme
commonly used as a marker to detect the senescent phenotype, was shown to increase
with age in various mammalian tissues (Krtolica and Campisi, 2002). Since stem cells
are capable of self-renewal and produce progeny to replenish worn-out and damaged cells
in aged tissues, the induction of stem cell senescence may compromise tissue renewal by
depletion of stem or progenitor cell pools and thus promote age-related pathologies.
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It is apparent that the HSC compartment undergoes considerable age-related
changes, however it is not yet clear whether theses changes are intrinsic to the cells
themselves or whether they occur due to alterations in the hematopoietic
microenvironment, commonly referred to as the HSC niche. Several studies have shown
that the systemic milieu regulates stem cell decline during aging. Liang et al. showed
that HSCs have a reduced ability to home to the bone marrow and spleen after
transplantation into old versus young recipients (Liang et al., 2005). Further experiments
demonstrated that the muscle stem cell niche adversely effects stem cell function as
evidenced by the restoration of old stem cell regenerative potential upon exposure to a
young systemic microenvironment (Conboy et al., 2005; Conboy and Rando, 2005). It
has also been reported that the spermatogonial stem cell niche deteriorates with age,
causing the failure to support an appropriate balance between stem cell self-renewal and
differentiation and ultimately resulting in age-related infertility in mice (Ryu et al.,
2006). It is likely that age-related HSC changes derive from intrinsic alterations as well
as extrinsic alterations of specific subtypes of cells in the HSC niche, thus adding another
layer of complexity to the stem cell aging process (Figure 1.4).
Genetic Regulation of HSCs
Cell intrinsic aging in B6 and DBA mice
Inbred strains of laboratory mice provide excellent models to study HSC
properties, such that strain specific phenotypic differences can be directly attributed to
underlying genetic differences in the stem cells. Specifically, the genetic regulation of
the age-related decline in stem cell function has been demonstrated extensively by
comparing this divergent phenotype among various mouse strains. Stem cells in the
relatively long-lived C57BL/6 (B6) mouse strain, measured by in vitro CAFC and in vivo
completive repopulation assays, increase in number during aging, whereas stem cells in
the DBA/2 (D2) strain decease over time and display overt signs of aging (Chen et al.,
1999; de Haan and Van Zant, 1999; Kamminga et al., 2005; Morrison et al., 1996; Yuan
et al., 2005) (Figure 1.5). When equal numbers of bone marrow cells from old and young
B6 mice are mixed with standard competitor cells and injected into lethally irradiated
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recipients, the old cells have a competitive advantage compared to young cells (Harrison
et al., 1989; Morrison et al., 1996). In stark contrast to these results, old stem cell
populations in the relatively short-lived D2 mice display a significant competitive
disadvantage compared to young cells (Chen et al., 2000; Harrison et al., 1989; Van Zant
et al., 1990). In a series of experiments performed by Van Zant et al. (1990) the straindependent differences in B6 and D2 stem cell aging were elegantly demonstrated. Eight–
cell embryos from B6 and D2 mice were combined ex vivo to form chimeric embryos that
were implanted into the uteri of pseudopregnant females (Van Zant et al., 1990). All
tissues in the resulting chimeric mice consisted of a mixture of B6 and D2 cells. During
aging of the chimeric animals, D2 HSC function progressively declined, evidenced by a
shift to the B6 genotype in all blood cell lineages by two years of age. The chimeric mice
showed complete tolerance to B6 and D2 cells, thus ruling out all possibility that the D2
genotype is selectively eliminated during aging (Mintz and Silvers, 1967). Thus the
chimeras allow for simultaneous assessment of two stem cell populations in a common
environment, demonstrating cell intrinsic stem cell aging properties in the two genetically
different mouse strains. It is probably not a coincidence that D2 hematopoiesis in the
chimeras ceased around the time of the strain’s natural lifespan. This leaves one to
postulate that there may be a link between the viability of HSC populations and the
longevity of organisms.
In addition to life span and HSC aging phenotypes, B6 and D2 mice show
significant strain-specific variation in multiple HSC paramaters. For example, in contrast
to what we observe in old animals, young D2 mice contain higher numbers of
hematopoietic stem and progenitor cells when compared to young B6 mice (de Haan and
Van Zant, 1999; Geiger et al., 2001). Other HSC strain specific differences include
higher proliferation or cycling activity in D2 hematopoietic cells (de Haan et al., 1997;
Van Zant et al., 1983), as well as reduced proliferation in response to early-acting
cytokines when compared to B6 cells (Henckaerts et al., 2002). Additional studies have
shown differences in the percentage of circulating white blood cells, B220+ B cells, as
well as CD8+ and CD4+ T cells between B6 and D2 mice (Chen et al., 2002). The
myriad differences that exist between the hematopoietic systems of B6 and D2 mice
provides a powerful approach to study the genetic control of HSCs.
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Forward genetic approach to study stem cell genes
The completion of the mouse and human genome sequencing projects has greatly
facilitated our ability to identify and characterize gene function at the level of the whole
organism. Specifically, in HSCs, both ‘gene-driven’ (reverse genetics) and ‘phenotypedriven’ (forward genetics) approaches have been utilized to identify genes and regulatory
pathways that influence stem cell function. Reverse genetics approaches rely on the
ability to manipulate the expression of a specific gene in the whole animal using
transgenic and knock-out strategies, while forward genetics approaches aim to identify
genetic polymorphisms that underlie naturally occurring phenotypes (Appleby and
Ramsdell, 2003). Due to the numerous differences in HSC properties that exist between
B6 and D2 mice, forward genetics approaches have been extremely successful in
identifying quantitative trait loci (QTL) (de Haan et al., 2002; de Haan and Van Zant,
1999; Geiger et al., 2001; Henckaerts et al., 2002) and genes (Liang et al., 2007) that
account for strain-specific stem cell properties. The use of recombinant inbred (RI)
strains has been vital in our quest to identify QTL and quantitative trait genes (QTG) that
underlie various HSC traits. Our lab uses the C57BL/6J cross DBA/2J (BXD) RI strains
due to the extensive differences between the hematopoietic systems of the B6 and D2
parental strains from which they were derived. RI lines are formed by the crossing of B6
and D2 parental strains, followed by repeated brother-sister mating (Figure 1.6). During
inbreeding, homologous recombination reshuffles the two parental genomes in a distinct
fashion, resulting in alleles that become fixed in a unique pattern (de Haan and Williams,
2005). The genome of each BXD strain has been mapped in great detail, thus regions of
B6 and D2 derived DNA can be genotyped, resulting in a strain distribution pattern
(SDP) for each individual BXD line. Each BXD strain is then phenotyped for the trait of
interest to derive a phenotype distribution pattern (PDP). A computer algorithm is used
to compare the SDP and PDP and determines the association between a particular trait
and B6 or D2 alleles at known marker loci. Significant associations between a trait and a
genotype define QTLs that contain the gene(s) that control the trait (Wang et al., 2003).
QTLs can only be mapped if the two parental strains have different alleles at a locus of
interest, therefore it is necessary to use two strains that show large natural variations in
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the parameter of interest (Van Zant, 2003). Once strain specific stem cell phenotypes are
identified, linkage analysis using BXD RI strains enables the genetic mapping of the
location of the QTL that contributes to the phenotype in question. Using this forward
genetic approach, we and others have been very successful at identifying numerous QTL
that underlie various HSC traits. QTL on chromosomes 1, 3, and 5 were found to
regulate the number of HSCs in young B6 and D2 mice (Geiger et al., 2001), while a
locus on chromosome 2 was shown to be the major determinant of stem cell number in
old mice (de Haan and Van Zant, 1999). Another QTL on chromosome 18 was linked to
the number of stem cells in both young and old animals (Geiger et al., 2001). QTL
governing other strain specific HSC traits such as the response of hematopoietic stem and
progenitor cells to early acting cytokines (Henckaerts et al., 2002), the fraction of
hematopoietic progenitor cells killed by the cytotoxic drug hydroxyurea, as well as the
mobilization efficiency of progenitor cells (Geiger et al., 2004) have also been mapped.
Interestingly, a QTL that regulates mouse lifespan was mapped to the same location on
chromosome 2 that regulates the number of HSCs in old mice (de Haan and Van Zant,
1999; Geiger et al., 2001), suggesting that stem cell pool size may have an effect on
longevity and that the same gene(s) may regulate the two traits. More recently, genetic
loci involved in controlling gene expression in HSCs have also been identified using a
“genetical genomics” approach. Using this strategy, global gene expression data are
collected from HSCs isolated from each BXD strain, and mRNA abundance for each
gene is treated as an individual trait that can be mapped to a particular region of the
genome (Bystrykh et al., 2005). QTLs that are responsible for variation in expression of
transcripts can be classified into two groups: cis-acting QTLs which are located at the
physical position of the transcript itself, and trans-acting QTLs that modulate the
expression of large numbers of genes throughout the genome. Cis-regulated transcripts
located in a QTL that controls a particular trait serve as good candidates for quantatittive
trait gene identification.
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Quantitation and Identification of HSCs and their Progeny
In vitro cobblestone area forming cell (CAFC) assay
It has long been established that the HSC compartment represents a hierarchy of
cells, separated on the basis of pluripotency, differentiation potential, and proliferation
rate. The CAFC assay is a convenient in vitro limiting-dilution assay used to predict the
frequency of different hematopoietic cell subsets in this hierarchy growing as
“cobblestones” underneath a stromal layer (Ploemacher et al., 1989). A pre-established
stromal layer, such as one established by FBMD1 cells, allows for the long-term growth
of stem cells in an in vitro setting. Primitive stem cells migrate beneath the stromal layer
and form colonies (cobblestones) at various time-points over a period of a month or
more. Cobblestones are defined as a cluster of at least five non-refractive cells growing
beneath the stromal layer. The longer the latency for a cobblestone to appear, the more
primitive in nature the cell. Thus, cells that form cobblestones on days 7 to 21
correspond to hematopoietic progenitor cells, while cells that form cobblestones on days
28 and 35, or later, are considered LT-HSCs. CAFC frequencies determined at various
culture times show good correlation with stem cell frequencies determined by more
expensive and time consuming in vivo assays discussed below (Ploemacher et al., 1992;
Ploemacher et al., 1991). The CAFC assay is a fast and relatively easy way to quantify
stem cells. However, the cell culture conditions used in the assay do not exactly mimic
the natural bone marrow microenvironemnt (which has been shown to be very hypoxic)
and the assay is not capable of measuring the in vivo homing ability of stem cells.
Therefore, the gold standard for measuring HSC activity remains in vivo repopulation
experiments.
In vivo competitive repopulation assays
As mentioned previously, HSCs have two distinct properties; 1) the ability to selfregenerate into cells that are functionally identical to the stem cell from which were
derived and 2) they are pluripotent and have the ability to differentiate into all of the eight
major lineages of lymphoid, myeloid and erythroid cells. These hallmark HSC properties
are measured empirically by their potential to regenerate and sustain the
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lymphohematopoietic compartment upon transplantation into lethally irradiated
secondary hosts. The first in vivo assay for stem cells was introduced by Till and
McCulloch (Till and McCulloch, 1961), in which they noticed that cells obtained from
the bone marrow or spleen of donor mice formed macroscopic colonies in the spleens of
lethally irradiated recipient mice. These spleen-colony forming units (CFU-S) could be
enumerated, therefore enabling the frequency of CFU-S in the initial cell inoculation to
be quantitated. Although it was later determined that CFU-S were not able to sustain
long-term hematopoiesis (Jones et al., 1990), this was the first ground-breaking assay for
the functional identification and quantification of HSCs in vivo.
The first assay to measure the true multilineage reconstitution potential of HSCs
in vivo was introduced by Harrison in 1980 (Harrison, 1980). This competitive
repopulation assay measures the functional potential of an unknown source of HSCs (test
cells) relative to a known number of distinguishable “competitor” cells. When equal
numbers of test and competitor cells are co-injected into lethally irradiated mice,
theoretically 50% of the hematopoietic cells in the recipient will be regenerated by each
population. However, any deviation from the 50% regeneration by one of the donors
indicates either a competitive advantage or disadvantage. Although this assay provides
information about the repopulating ability of HSCs compared to competitor cells, it
cannot distinguish between increased/decreased proliferation of individual HSCs and an
actual increase/decrease in absolute HSC numbers. To address this problem the standard
competitive repopulation assay was modified to introduce a limiting dilution design, in
which graded doses of donor test cells are injected into lethally irradiated, but genetically
distinguishable, recipient mice along with a set number of competitor cells to ensure
survival of the recipient even when the test cell sample contains little or no repopulating
activity (Szilvassy et al., 1990). The number of mice negative for reconstitution in each
cell dose is then measured several months later, and the frequency of HSCs (defined as
competitive repopulating units, CRU) is calculated using Poisson statistics and the
method of maximum likelihood (Szilvassy et al., 1990; Szilvassy et al., 1989).
Both the standard competitive repopulation assay and the CRU assay take
advantage of the Ly5 congenic B6 mouse strains whose white blood cells can be
distinguished by their expression of the a (Ly5.1) or b (Ly5.2) forms of the ptprc
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alloantigen. Typically, wild-type B6 mice expressing the Ly5.2 allele are used as donors
and B6.SJL(Boy J) mice expressing the Ly5.1 allele are used for competitor cells and
recipients. Test cell (donor) contribution to myeloid and lymphoid cells in the recipient
is then quantitated by flow cytometric analysis of cells stained with fluorescently labeled
Ly5.1 and Ly5.2 antibodies.
Flow cytometric identification of HSCs
Great advances in flow cytometry over the past several years have allowed the
isolation of highly purified primitive stem cell populations. Using fluorescently labeled
antibodies directed against specific cell surface receptors, it is possible to identify,
quantify, and sort various hematopoietic cell subsets to near purity. Although several
approaches have been developed, staining for the presence or absence of cell surface
markers is the most commonly used strategy to separate different hematopoietic
populations. The general consensus is that primitive stem cells are characterized by the
absence of lineage antigens expressed on differentiated cells such as granulocytes,
macrophages, B and T lymphocytes, and erythrocytes. Further enrichment of HSCs
relies on the presence of Sca-1, a membrane glycoprotein, and c-kit, a tyrosine kinase
receptor (Ogawa et al., 1991; Spangrude et al., 1988). The Lineage- Sca-1+ c-Kit+
(LSK) cells comprise ~0.1% of the whole bone marrow and are considered to be highly
enriched for HSCs.
In the last few years, a new cell surface phenotype based on the presence and
absence of SLAM proteins, has been used to purify a population of which ~50% of single
cells reconstituted lethally irradiated animals (Kiel et al., 2005). SLAM proteins are a
group of 10-11 cell surface receptors that regulate the proliferation and activation of
lymphocytes (Howie et al., 2002; Wang et al., 2004). Primitive HSCs are highly
enriched within the CD150+ CD48- cells population. Further, SLAM proteins are
expressed by many mouse strains and appear to be conserved among HSCs from old,
mobilized, and transplanted cells (Yilmaz et al., 2006), thus ensuring the purity of HSCs
when examining cells across a variety of contexts.
Another widely used HSC purification strategy relies on the robust ability of
HSCs to efflux a variety of compounds (Goodell et al., 1996). Efflux of the fluorescent
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DNA binding dye Hoechst 33342 results in a “side population” (SP) of cells that is
enriched for HSCs. SP cells were shown to be enriched ~1000 fold for HSC activity, and
provided long-tern mulitlineage contribution in lethally irradiated recipients (Goodell et
al., 1996). Inclusion of the canonical LSK cell surface markers in combination with the
Hoechst 33342 efflux property allows for even further enrichment for HSCs, yielding a
population termed SParKLS (LSK cells in the SP) (Lin and Goodell, 2006).
Mapping of a QTL Linked to the Change in HSC Number in Old B6 and DBA Mice
The strain specific HSC aging phenotype between B6 and D2 mice is the focus of
this dissertation. As mentioned previously, when using the CAFC assay to measure HSC
frequency, our lab found that the stem cell population in long-lived B6 mice increases
steadily with age, whereas the frequency of HSCs in the relatively short-lived D2 strain
follows a bell shaped curve throughout life, reaching a peak at ~1 year then declining in
old age (Figure 1.5) (de Haan and Van Zant, 1999). In order to understand the genetic
basis for the variation of HSC numbers in old B6 and D2 mice, we used the
aforementioned forward genetic approach and performed genetic linkage analysis in
BXD RI strains of mice. Using this approach, we identified a locus on murine
chromosome 2 that is significantly linked to the variation in frequency of HSCs in aged
B6 and D2 animals. The locus on chromosome 2 was linked to the number of HSCs only
in old animals, thus qualifying as a true “aging locus” at which the B6 allele is
responsible for the expansion of HSCs in old B6 animals (de Haan and Van Zant, 1999).
In order to definitively associate stem cell aging with the QTL identified on chromosome
2, our lab created congenic mice in which the distal region of chromosome 2 containing
the QTL was transferred from D2 mice onto a B6 background. The introgressed D2
genomic interval was derived from BXD strain 31 because it phenotypically best
demonstrated the decline in HSCs in old age. Using a speed congenic approach, BXD31
mice were backcrossed to the B6 parental strain to expunge D2 DNA located outside of
the QTL region (Wakeland et al., 1997). The generation of mice using a speed congenic
approach relies on genotyping each generation for the distribution of allelic markers
every 10 cM along the entire mouse genome. Mice with the greatest amount of parental
DNA and bearing donor alleles at the QTL are then chosen for further backcrossing. The
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resulting chromosome 2 congenic mice have a genome that is ~99% B6 with the
exception of the introgressed D2 congenic interval spanning 50 Mbp on the end of
chromosome 2. Congenic mouse models are very powerful tools when studying QTLs,
as they allow for the confirmation that a particular chromosomal locus does influence a
particular trait. Essentially one can determine if in fact “the phenotype follows the
genotype.” We next hypothesized that congenic B.D Ch2 mice (hereafter referred to
simply as congenics), in which the QTL interval in B6 mice has been replaced by D2
alleles, would confer the D2 phenotype of decreased HSCs numbers only in aged mice.
To test our hypothesis, CAFC d35 frequency was measured in young and old B6
background and congenic mice. At 2 months of age, the frequency of HSCs in congenic
bone marrow did not differ significantly from the frequency HSCs in B6 animals. In
contrast, at 24 months of age, the frequency of HSCs in congenic bone marrow was a
statistically significant 2-fold less than in age-matched B6 mice (Figure 1.7A). Because
bone marrow cellularity showed only a modest 20% increase in old animals, the
decreased frequency of HSCs in old congenic mice represents a decrease in the absolute
number of HSCs in their bone marrow (Geiger et al., 2005).
Because stringent testing of stem cell activity and frequency is best accomplished
by in vivo transplantation experiments, an additional competitive repopulation experiment
was performed in which equal numbers of congenic or B6 bone marrow cells were mixed
with an equal number of competitor cells and injected into lethally irradiated mice. In
contrast to almost equal contribution to PB at early time points, the contribution of
congenic cells to peripheral blood chimerism eleven months post transplant was
significantly less than contribution from B6 cells (Figure 1.7B). Thus, in vitro and in
vivo results confirmed the linkage analysis, and demonstrated that the influence exerted
by the D2 allele caused a significant reduction in HSC frequency and activity with age
(Geiger et al., 2005).
Aging phenotypes in mice are difficult to study, partly because test subjects must
age ~2 years before they can be used in an experiment. In order to overcome this hurdle,
as well as to determine if DNA integrity influenced stem cell aging, we administered
either 1 or 2 Gy of gamma radiation to congenic and B6 animals, a treatment we
hypothesized would cause DNA damage and partial depletion of the stem cell pool, thus
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creating a prematurely aged the stem cell population (Figure 1.8A). Two weeks post
irradiation, we injected the test cells (B6 or congenic) along with an equal number of
competitor cells into lethally irradiated mice. As expected, bone marrow cells from mice
given no radiation contributed equally to peripheral blood (PB) chimerism in recipient
animals up to 20 weeks post transplant. Bone marrow from congenic mice given 1 Gy,
which results in ~20-30 chromosomal breaks per genome, displayed an initial defect in
contribution to PB chimerism, but by 20 weeks post transplant showed an equivalent
contribution to PB as did B6 cells. In contrast, BM from congenic animals receiving 2
Gy contributed only 10% of PB cells at 8 weeks following transplant, and this low
contribution remained unchanged for the duration of the experiment, a finding consistent
with stem cell exhaustion due to radiation (Figure 1.8B) (Geiger et al., 2005). Thus,
although low dose irradiation does not precisely mimic the natural aging process, it does
elicit a phenotypic response in young congenic mice that can be measured in a relatively
short period of time and confirms the notion that DNA damage in stem cells leads to stem
cell aging.
Experimental Goals and Significance
The experimental goal of the work performed in this dissertation was to identify
specific gene(s) and molecular pathways underlying HSC aging in two commonly used
strains of inbred mice using a forward genetic approach. Three specific aims are
proposed to accomplish this goal: 1) to confirm the phenotype of the congenic mouse
model in highly purified CD150+CD48- stem cells and to study the mechanistic basis for
the difference in HSC numbers in old mice by looking at self-renewal, cell cycle, and
apoptosis in B6 and congenic mice using a previously established irradiation study to
mimic the natural aging process; 2) to perform microarray analyses using stem and
progenitor enriched hematopoietic cells from B6 and congenic mice in order to identify
genes that are differentially expressed between the strains that may contribute to the
different HSC aging phenotypes; and 3) to overexpress candidate gene(s) identified in the
microarray analysis in primary hematopoietic cells and perform functional studies in
order to determine whether their overexpression results in quantitative changes in HSC
number.
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Human HSCs undergo similar age-related changes as do the mouse, thus it is
probable that some of the genes and regulatory mechanisms uncovered with our murine
model will be applicable to human HSC biology. Therefore these studies are important
because they may lead to the identification the genes that regulate and control the number
of HSCs in aged humans as well as mice. Further, these studies may identify genes that
serve as biomarkers to distinguish an individual’s ability to serve as “good” or “bad”
bone marrow transplant donors. In view of the importance of stem cells for maintaining
immune function and in a broader sense tissue homeostasis and longevity, there is a
critical need to better understand the mechanisms involved in HSC aging.
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Figure 1.1 The HSC hierarchy.
The HSC compartment can be functionally divided into three populations; long-term
HSCs, which have extensive self-renewal capacity, short-term HSCs, which have limited
self-renewal capacity, and multipotent progenitor cells which cannot self-renew and give
rise to common lymphoid progenitors (CLP) and common myeloid progenitors (CMP).
CLPs differentiate into pro-B, T, and natural killer (NK) cells, which then give rise to
mature B and T cells and NK cells. CMPs differentiate into granulocyte/macrophage
progenitors (GMP) and mekaryocyte/erythroid progenitors (GEP). GMPs then give rise
to mature macrophages and granulocytes. GEPs differentiate into megakaryocyte
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progenitors (MkP) and erythroid progenitors (ErP), which give rise to platelets and
erythroblasts, respectively. Both GMPs and CLPs can give rise to mouse dendritic cells.
Reprinted by permission from Macmillan Publishers Ltd: [Nature] Reya, T, Morrison, SJ,
Clarke MF, Weissman IL. 2001. Stem cells, cancer and cancer stem cells. Nature
414:105-111, copyright (2001).
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Figure 1.2 Epigenetic changes that accompany aging and tumorigenesis.
Normal young stem cells undergo controlled self-renewal divisions and differentiate to
produce large numbers of high-quality mature cells. These well-orchestrated processes
rely heavily upon regulated epigenetic modifications of gene expression. However, as
stem cells age, their functional attributes decline. They have a reduced capacity for selfrenewal and differentiate to give rise to fewer, low-quality daughter cells. A general loss
of repression, resulting in dysregulation of gene expression and decreased chromatin
stability, also accompany the aging process. It is hypothesized that, in addition to
alterations in gene expression and reduced chromatin stability, the aging
microenvironment creates conditions permissive to cancer development. Subsequent
cancer-promoting epigenetic events, including silencing of tumor suppressor genes and
activation of oncogenes promote the transition from a normal to a cancerous state. The
cancer stem cell has extensive self-renewal capacity and differentiates to give rise to selfrenewing (disease sustaining) as well as terminally differentiated progeny. It is important
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to note, however, that the cancer stem cell does not necessarily have to arise from aged
stem cell populations, but instead can arise from young stem cells whose normal
developmental processes have gone awry. Reprinted by permission from Macmillan
Publishers Ltd: [Leukemia] Oakley, E.J., and Van Zant, G. 2007. Unraveling the complex
regulation of stem cells: implications for aging and cancer. Leukemia 21:612-621,
copyright (2007).
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Figure 1.3 Decline in human HSCs with advancing age.
Human HSCs, defined as CD34+ cells, show a steady decline in number as individuals
age.
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Figure 1.4 Stem cell theory of aging.
Schematic representing the stem cell theory of aging as it pertains to the hematopoietic
system. Aging results in the accumulation of damage in the HSC compartment, which in
turn leads to compromised function of this system and ultimately reduced health of the
entire organism. Adapted from Waterstrat, A., E. J. Oakley, A. Miller, and G. Van Zant.
Stem cells and aging. Modified from Telomeres and Telomerase in Aging, Disease, and
Cancer. L. Rudolph, ed. Springer, Berlin, 2007.
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Number of CAFC d35 cells/mouse
Figure 1.5 Frequency of CAFC day35 cells in young and old B6 and D2 mice.
The frequency of CAFC day35 cells in B6 mice increases in a linear fashion with age,
whereas the frequency of CAFC day35 cells in the D2 strain follows a bell shaped curve
throughout life, with HSC numbers reaching a peak at ~1 year then declining in old age.
Modified from de Haan, G., and Van Zant, G. 1999. Dynamic changes in mouse
hematopoietic stem cell numbers during aging. Blood 93:3294-3301.
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Figure 1.6 Illustration of the derivation of BXD RI strains of mice.
C57BL/6J cross DBA/2J (BXD) RI strains are created by the crossing of B6 and D2
parental strains, followed by repeated brother-sister mating of their progeny for 20
generations. The alleles in each RI line become fixed in a unique fashion, thus each
strain becomes a mosaic of the two parental genomes. Phenotypes are correlated with B6
or D2 alleles present at specific markers located throughout the mouse genome. This
linkage analysis has enabled the genetic mapping of numerous QTL that influence
various HSC phenotypes.
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Figure 1.7 In vitro and in vivo confirmation of the chromosome 2 QTL.
Decreased frequency of LSK cells, as measured by the CAFC assay, in old congenic mice
compared with the frequency in old B6 mice (P < 0.05) (A). Bone marrow from two
animals for each strain was analyzed in six CAFC assays per animal. Equal numbers of
competitor and either B6 or congenic bone marrow cells were co-injected into lethally
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irradiated recipient mice, and the animals were aged 10 months. Chimerism in the
peripheral blood of the recipients was determined at various time points after
transplantation. Congenic stem cells displayed a significant competitive disadvantage in
aged animals compared to cells in B6 mice (P < 0.05) (B). From Geiger, H., Rennebeck,
G., and Van Zant, G. 2005. Regulation of hematopoietic stem cell aging in vivo by a
distinct genetic element. Proc Natl Acad Sci U S A 102:5102-5107. Copyright (2005)
National Academy of Sciences, U.S.A.
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Figure 1.8 Irradiation scheme to mimic HSC aging.
Diagram of the competitive repopulation assay used for these analyses (A). B6 and
congenic mice were given 0, 1 or 2 Gy of irradiation, and after a resting period of two
weeks, bone marrow cells were harvested and transplanted in equal numbers into lethally
irradiated recipient mice. Chimerism in the peripheral blood of the recipients was
determined at various time points after transplantation (B). n = 4 mice for each dose.
Adapted from Geiger, H., Rennebeck, G., and Van Zant, G. 2005. Regulation of
hematopoietic stem cell aging in vivo by a distinct genetic element. Proc Natl Acad Sci U
S A 102:5102-5107. Copyright (2005) National Academy of Sciences, U.S.A.
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CHAPTER TWO
Analysis of self-renewal, cell cycling, and apoptosis in hematopoietic stem and
progenitor cells in congenic and background mice using the surrogate aging assay
Summary
It has previously been established that a quantitative trait locus (QTL) on murine
chromosome 2 regulates the change in the number of hematopoietic stem cells (HSCs) in
old C57/B6 (B6) and DBA2 (D2) mice. Congenic mice were created by introgressing D2
alleles onto a B6 background, and in vitro and in vivo studies confirmed that these mice
display the D2 phenotype of reduced HSC number and function in old age. Further, a
surrogate assay for the HSC aging phenotype was established in which low-dose
radiation was administered to young mice to simulate the stress of aging on the HSC
population. Young congenic HSCs were found to be extremely sensitive to 2 Gy of
irradiation compared to young B6 HSCs. However, the underlying mechanisms that
account for differences in HSC number in old B6 and congenic mice as well as the
differential radiation sensitivities are not yet known. Therefore in these studies, I
investigated the cell cycle, apoptotic, and self-renewal capacity of B6 and congenic HSCs
subject to 2 Gy of irradiation using various flow cytometry and serial bone marrow
transplantation techniques. I used the surrogate assay to mimic aging with hopes of
identifying common mechanisms that may be differentially regulated in aged B6 and
congenic mice. Additionally, I further confirmed the phenotype of the congenic mouse
model and showed that old congenic mice have 39% fewer CD150+ CD48- than do old
B6 mice. I did not detect any significant differences in the percentage of cells in S phase
in whole bone marrow, lineage negative (Lin-), or Lin- Sca-1+ c-kit+ (LSK) cells
between B6 and congenic mice subject to 2 Gy of irradiation. However, when analyzing
the apoptotic status of these cell populations after 2 Gy of irradiation, I demonstrate that
B6 Lin- cells undergo significantly more apoptosis (34.7%) than do similarly treated
congenic Lin- cells (12.4%). Under steady-state conditions (no irradiation), I observed
no difference in the percentage of whole bone marrow, Lin- and LSK cells undergoing
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apoptosis between B6 and congenic mice. Finally, serial transplantation experiments
revealed a dramatic repopulation advantage in B6 mice treated with 2 Gy of irradiation
compared to similarly treated congenic mice in all recipient groups, thus indicating that
the D2 alleles in the chromosme 2 QTL confer lower self-renewal capacity of HSCs
exposed to 2 Gy of irradiation. In sum these results indicate that the chromosome 2 QTL
affects the apoptotic and self-renewal capacity of artificially aged hematopoietic stem and
progenitor cells, which may account for the variation in HSC number in old B6 and D2
mice.
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Introduction
Hematopoietic stem cells must balance self-renewal, differentiation, and cell
death decisions in order to sustain hematopoiesis throughout the lifetime of an organism
as well as be poised for extensive proliferation upon demand. The normal fate decisions
of stem cells can easily be summarized: a) a stem cell may remain quiescent and not
divide at all; b) a stem cell may undergo symmetric cell divisions to generate two new
self-renewing stem cells or two new differentiated progeny; c) a stem cell may undergo
asymmetric cell divisions and give rise to one new stem cell and one differentiated cell;
and finally d) a stem cell may undergo apoptosis and no longer contribute to
hematopoiesis (Figure 2.1). There is strong evidence that cell intrinsic factors tightly
regulate the survival, differentiation, and proliferation of stem cells, and thus ultimately
influence the functional quality and size of the hematopoietic compartment throughout
the lifetime of an organism.
The small number of HSCs in an adult mouse must replace approximately 2.4 x
108 red bloods cells and 4 x 106 non-lymphoid peripheral blood cells each day (Cheshier
et al., 1999) as well as be ready to proliferate in response to hematological stresses.
According to the clonal-succession hypothesis which was first proposed in 1965, HSCs
meet the great demands of hematopoiesis by allowing only one or a few HSC clones to
give rise to mature blood cells at any one time (Kay, 1965). According to this model,
other HSCs in the pool remain quiescent and do not contribute to hematopoiesis until the
proliferative capacity of the active HSC is exhausted. However, Pietrzyk and Bradford
later challenged this theory when they analyzed in vivo bromodeoxyuridine (BrdU)
incorporation rates of day 14 CFU-S and Hoechst low (Holo), Rhodanmine123 low (Rholo)
enriched HSCs, respectively (Bradford et al., 1997; Pietrzyk et al., 1985). Pietrzyk et al.
showed that 75% of progenitors capable of forming day-14 CFU-S had incorporated
BrdU over a period of one month (Pietrzyk et al., 1985) and Bradford et al. demonstrated
that 89% of HoloRholo cells incorporated BrdU over a period of 12 weeks (Bradford et
al., 1997). Cheshier et al. went on to show that 99% of HSCs incorporated BrdU by the
end of six months, thus clearly demonstrating that all HSC do in fact cycle on a regular
basis (Cheshier et al., 1999).

This high proliferative capacity of HSCs allows for
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emergency responses, but under steady state conditions, must be tightly regulated in order
to maintain hematopoietic homeostasis.
Perhaps one of the most important factors in sustaining hematopoietic
homeostasis and preventing exhaustion of the stem cell pool throughout the lifespan of an
organism is maintaining appropriate cell cycle control. Cyclin dependent kinase
inhibitors (CKIs) halt cell cycle progression and have been shown to play an important
role in stem cell regulation (Cheng et al., 2000; Walkley et al., 2005; Yuan et al., 2004).
p21cip1/waf1 (p21), a G1 checkpoint regulator highly expressed in the quiescent fraction of
bone marrow cells, has been shown to restrict HSC cycling and thus maintain stem cell
quiescence and survival. p21-deficiency increases HSC proliferation and amplifies and
the size of the HSC pool under homeostatic conditions in the mouse (Cheng et al., 2000).
The proportion of quiescent cells in G0 phase of the cell cycle is reduced in p21-/- mice,
and in agreement with these findings, p21-/- mice are more sensitive to 5-flurouracil, a cell
cycle specific toxin that kills cycling cells, than wild-type controls. Further, the
hematopoietic potential of p21 deficient HSCs was nearly exhausted after two rounds of
serial bone marrow transplantation (Cheng et al., 2000). Together these results indicate
p21 as a key regulator of stem cell cycling that functions to prevent stem cell exhaustion
under prolonged stress (Ezoe et al., 2004).
Unlike p21, p27KIP1 (p27) is a CKI whose expression is observed in more mature
progenitors cells. The number, cell cycling, and self-renewal of HSCs were found to be
normal in p27 deficient mice, however the mice displayed an increase in the number and
proliferative capacity of progenitor cells (Cheng et al., 2000). Progenitor cells from p27
null mice were able to expand and regenerate after serial transplantation, thus indicating
p27 as an important modulator of the repopulation efficiency but not overall pool size of
HSC cells (Cheng et al., 2000). In contrast to p21 studies, yet similar to p27 findings,
HSCs deficient in p18INK4C (p18), a member of the INK4 family of CKIs, display
diminished cell exhaustion compared to wild-type cells after serial transplantation over
three years (Yu et al., 2006). Interestingly, deletion of p18 was able to counteract the
accelerated exhaustion of HSC repopulation resulting from p21 deficiency. The
advantage imparted to p18 deficient cells is thought to be due to increased self-renewal of
the transplanted HSCs in vivo rather than increased donor cell proliferation (Yuan et al.,
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2004). These studies demonstrate the importance of CKIs in regulating HSC cell cycle
kinetics and also indicate the highly divergent effects that cell cycle inhibitors can have
on stem cell function.
Unlike p21, p27 and p18, which have not been directly linked to stem cell aging,
the stem cell intrinsic effects of p16INK4a have been linked to age-dependent changes in
stem cell function. In B6 HSCs, p16 INK4a mRNA expression was shown to increase with
age. Thus, in order to determine the functional role of this protein, Janzen et al.
examined the hematopoietic system of mice deficient in p16INK4a (Janzen et al., 2006).
They found that, in contrast to young animals in which no differences were found, the
frequency of old HSCs was increased in p16INK4a-/- animals compared to wild-type. They
also showed that old p16INK4a-/- HSCs had increased self-renewal capacity when
compared to wild-type cells in serial transplantation assays, thus suggesting that the
absence of p16 INK4a improved HSC function under conditions of stress. They propose
that inhibition of p16INK4a may prevent some of the age-related changes that occur in old
stem cells.
Several studies suggest that, in addition to cell cycle regulators, apoptosis plays an
important role in homeostasis of stem cell numbers both under steady state conditions as
well as during the aging process. For example, increased numbers of HSCs were found in
the bone marrow of transgenetic mice overexpresssing BCL-2 (an anti-apoptotic protein)
in all hematopoietic tissues (Domen et al., 2000). BCL-2 overexpression has also been
shown to protect HSCs from radiation- and growth factor deprivation-induced cell death
(Domen et al., 2000; Domen et al., 1998). Further, HSCs overexpressing BCL-2
displayed a competitive repopulation advantage in transplantation assay, thus clearly
establishing apoptosis as an important mechanism in regulating HSC numbers in vivo
(Domen, 2001; Domen et al., 2000).
Apoptotic pathways have also been implicated in regulating HSC dynamics in
aged stem cell populations. Cellular aging is associated with the accumulation of DNA
damage and genomic instability, thus it has been hypothesized that proteins that regulate
DNA damage response pathways are key regulators of aging (Dumble et al., 2007). p53
is a tumor suppressor protein that is activated in response to numerous cellular stresses,
including DNA damage and oncogenic activation, to induce cell cycle arrest and/or
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eventual apoptosis. Mice expressing a hyperactive p53 protein display a heightened
tumor resistance, and surprisingly significantly reduced longevity compared to wild-type
mice (Tyner et al., 2002). The mutant mice showed generalized organ atrophy and
reduced tolerance to stress beginning in middle age that become more apparent in old
age. Relevant to this discussion, aged p53 mutant mice also displayed a reduced ability
to generate white blood cells after ablation of hematopoietic progenitors with 5flurouracil. It was hypothesized that reduced HSC function drove the decrease in
regenerative capacity. Indeed, subsequent experiments showed that B6 mice expressing
hyperactive p53 (p53+/m) failed to exhibit age-associated increases in stem cell number
(consistent with wild-type B6 mice), and in fact showed a reduced number of HSCs
compared to age-matched p53+/+ and p53+/- mice. In addition, HSC proliferation was
found to be inversely correlated with p53 activity, with p53+/- mice retaining the highest
level of proliferative capacity at old age (Dumble et al., 2007). Although the mechanism
by which p53 reduces HSC proliferation and functionality is not yet known, a clear role
for the pro-apoptotic p53 protein has been established in the HSC aging process. A
scenario is favored in which altered p53 dosage affects the self-renewal capacity of
HSCs, which overtime results in functional differences in the hematopoietic
compartments of mutant and wild-type animals (Dumble et al., 2007).
Perhaps the most important regulators of HSCs are those that govern self-renewal
decisions. Self-renewal is crucial for stem cell function because it is required for stem
cells to persist throughout the lifetime of the animal. Numerous cell intrinsic
transcription factors, transcriptional repressors, and signaling molecules have been
indicated as important regulators of stem cell self-renewal and maintenance. For
example, homeobox (Hox) genes, which encode transcription factors that regulate
segment identity in the developing embryo, have been identified and implicated in the
regulation of various stages of hematopoiesis (Abramovich and Humphries, 2005;
Abramovich et al., 2005; Lawrence et al., 1996; Lewis, 1978). In particular, HoxB4 has
been considered an important regulator of primitive HSCs because it is expressed highly
in human CD34+ cells but is rapidly down-regulated upon differentiation (Sauvageau et
al., 1994). Overexpression of HoxB4 in the bone marrow compartment was shown to
increase HSC numbers, thus suggesting it acts as a positive regulator of HSC self-renewal
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(Antonchuk et al., 2002; Krosl et al., 2003; Miyake et al., 2006; Sauvageau et al., 1995).
Because maintanence of the HSC compartment is governed by a balance between growth
promoting signals as well as signals that promote senescence and apoptosis, one group
sought to determine the combined effects of HoxB4 overexpression and p21 downregulation (Miyake et al., 2006). As mentioned previously, p21 acts to maintain HSCs in
a quiescent state, therefore it was hypothesized that p21 deficiency would enhance the
HoxB4-mediated increase in self-renewal capacity. Indeed it was found that the
simultaneous modulation of p21 and HoxB4 generated a ten- fold increase in the number
of repopulating HSCs after 5 days of ex vivo culture (Miyake et al., 2006). Another
transcription factor, Growth factor independence 1 (Gfi1), controls HSC self-renewal by
restricting their proliferation potential (Hock et al., 2004; Zeng et al., 2004). Gfi1
deficiency was shown to increase HSC proliferation and decrease repopulation efficiency
during serial transplantation. In fact, Gfi1 is thought to be an upstream regulator of p21,
whose expression is decreased in Gfi1 null cells. Factors that govern HSC self-renewal
and cellular fate decisions must be tightly controlled both to prevent premature
exhaustion and to maintain the integrity of the HSC population.
Clearly, HSC population kinetics are governed by highly orchestrated processes
that must remain balanced throughout the lifespan of an organism. The fact that all HSCs
are regularly cycling means that the fate of this cell population has to be determined
continuously. The regulation of HSC numbers has to be strictly controlled not only to
prevent unwanted expansion, but also to prevent premature contraction or aging of this
important cell population. Therefore, in order to address the potential mechanisms that
contribute to the cell-intrinsic differences in HSC number in old B6 and D2 mice, I
investigated the self-renewal, cell cycle, and apoptotic status of young B6 and congenic
mice that were given 2 Gy of irradiation. I used a previously established surrogate aging
assay, involving low dose irradiation, with hopes of identifying common mechanisms
that may be differentially regulated in aged B6 and congenic mice.
Before performing the mechanistic studies I first sought to determine whether the
congenic stem cell aging defect was observed in a CD150+ CD48- cell population.
Recently, it has been shown that HSCs can be highly enriched using a simple
combination of antibodies directed against the SLAM family member proteins CD150
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and CD48 (Kiel et al., 2005; Kim et al., 2006; Yilmaz et al., 2006). CD150+ CD48bone marrow cell populations contain 21% long-term multi-lineage reconstituting cells
when intravenously injected into lethally irradiated mice (similar to results obtained with
LSK cells) and it has been shown that SLAM family receptor expression is conserved
among young and old HSCs (Kiel et al., 2005; Yilmaz et al., 2006). Our lab has
previously shown that D2 alleles in the chromosome 2 QTL confer a decrease in CAFC
day 35 cells in old age, as well as an in vivo competitive disadvantage when compared to
B6 alleles (Geiger et al., 2005). To further confirm the phenotype of the congenic
mouse model and to ensure that I am studying functionally similar cells in young and old
mice, I measured the number of CD150+ CD48- cells in the bone marrow of these mice
relative to that of B6.
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Materials and Methods
Animals
Young (2-4 months) and old (24-25 months) C57BL/6 (B6) (Ptprcb [CD 45.2])
mice were purchased from the National Institute of Aging (NIA) Aged Mouse Colony at
Harlan Sprague Dawley (Indianapolis, IN). Chromosome 2 congenic mice, with a
genetic interval from D2 mice spanning 50 Mbp (130Mbp -180 Mbp) on the distal end of
chromosome 2, were generated as described previously (Geiger et al., 2005). Young (2-4
months) and aged (24-27 months) congenic animals were used in the experiments.
B6.SJL (Ptprca [CD 45.1] were purchased from the Jackson Laboratories and were used
as adoptive recipients in serial transplantation assays. All mice were female and were
housed in the Division of Laboratory Animal Resources (DLAR) at the University of
Kentucky Chandler Medical Center and were maintained under pathogen-free conditions
according to NIH guidelines for animal welfare.
Immunofluorescent staining of cells and flow cytometry
Mice were euthanized by CO2 asphyxiation and the femora and tibiae were
removed to a Petri dish containing Hanks Balanced Salt Solution (HBSS, GIBCO)
supplemented with 2% fetal bovine serum (FBS, Invitrogen). Femora and tibiae were
flushed with 4 mL media to obtain a single cell suspension. Mononucleated cells were
obtained via Ficoll gradient separation and Fc receptors were subsequently blocked with
anti-CD16/32 (clone 2.4G2, Fc Block) to prevent non-specific staining. For Lineage
negative (Lin-) isolation, cells were identified by the lack of cell surface antigens
characteristic of cells committed to individual lineages of blood cell development. The
lineage cocktail consisted of the following antibodies: CD5 (clone 53-7.3) and CD8a
(clone 53-6.7) to identify T cells, CD45R/B220 (clone RA3-6B2) to identify B cells,
CD11b/Mac-1 (clone M1/70) and Ly-6G/Gr-1 (clone RB6-8C5) to identify macrophages,
and Ter119/Ly-76 (clone Ter-119) to identify erythrocytes. All antibodies were
biotinylated, and immunofluorescent staining was achieved with streptavidin-fluorescein
isothiocyanate (SA-FITC). Light density bone marrow cells were stained with the above
lineage cocktail as well as stem cell specific cell surface markers, phycoerythrin (PE)-
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conjugated Ly-6A/E (Sca-1; cloneE13-161.7) and allophycocyanin (APC)-conjugated
CD117 (c-kit; clone ne2B8) to identify a population enriched in stem cells (Lin-, Sca-1+,
c-kit+ cells or LSK cells). In order to isolate rare CD150+ CD48- cells, whole bone
marrow was centrifuged over a Ficoll gradient to enrich for mononucleated cells, and the
recovered low-density cells were then labeled with antibodies directed against the SLAM
receptors. CD150+ CD48- cells were identified by staining with PE-conjugated antimouse CD150 (clone TC15-12F12.2) and FITC-conjugated hampster antimouse CD48
(BCM). In order to determine the number of CD150+ CD48- cells per 2 femora and 2
tibiae, cell counts were performed following Ficoll gradient centrifugation on a
hemocytometer. Cell counts were then divided by the number of mice used in the
experiment and then multiplied by the percent total CD150+ CD48- cells as determined
by flow cytometry staining, thus yielding the total number of CD150+ CD48- cells per 2
femora and 2 tibiae. For each cell preparation, dead cells were excluded by propidium
iodide (PI) staining. All monoclonal antibodies were purchased from BD Pharmingen.
Cells were analyzed and sorted on a triple-laser FacsVantage (Becton-Dickinson) flow
cytometer.
Cell Cycle Analyses
Cell cycle analyses were carried out in young B6 and congenic mice using the in
vivo BrdU incorporation assay (Dolbeare et al., 1990). BrdU is a thymidine analog that is
incorporated into newly synthesized DNA by cells entering and progressing through the S
phase of the cell cycle. BrdU can be stained with anti-BrdU fluorescent antibodies in
cells to determine the frequency of cells in a population that are synthesizing DNA.
Mice were injected intraperitoneally with BrdU (1 mg per kg of body weight) at various
time points (0h, 6h, 16h, 3d, 7d) following 2 Gy of gamma irradiation (whole body)
delivered from a 137Cs source Mark 1 Irradiator (J.L. Shepherd and Associates) at a dose
rate of 1.73 Gy per minute. One-hour post injection the mice were sacrificed and their
bone marrow LSK cells were enumerated as described above. Analysis of BrdU
incorporation in whole bone marrow, Lin-, and LSK cells was performed using a BrdU
Flow Kit (BD Pharmingen) according to the manufacturer’s directions. Cells in S phase
were identified as having a DNA content intermediate between diploid and tetraploid and
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staining positive for BrdU. Flow cytometric analysis was performed on a FACSVantage
(Becton-Dickinson). For a given time point, we performed a 3 way ANOVA with strain,
cell cycle phase (GO/G1, S, G2/M), and cell population (WBM, Lin-, LSK) as factors.
We then determined if there were significant inter-strain differences for a particular time
and cell cycle phase.
Apoptotic analysis of cells
Apoptosis is characterized by a variety of morphological features such as
blebbing of plasma and nuclear membranes, aggregation of nuclear chromatin, and
disruption of cytoskeletal architecture (Israels and Israels, 1999). In the early stages of
apoptosis, phosphatidylserine (PS), a membrane phospholipid, is translocated from the
inner to the outer leaflet of the plasma membrane, thereby exposing PS to the external
cellular environment (Martin et al., 1995). Annexin V is a Ca2+ dependent phopholipid
binding protein that has high affinity for PS, and is useful for identifying apoptotic cells
with exposed PS (Vermes et al., 1995). Annexin V conjugated to FITC will be used as a
probe for flow cytometric analysis of cells undergoing apoptosis.
Young B6 and congenic mice were given 0 or 2 Gy of gamma radiation (whole
body) from a 137Cs source Mark 1 Irradiator (J.L. Shepherd and Associates) at a dose rate
of 1.73 Gy per minute 2 hours prior to sacrifice. Bone marrow cells were isolated and
stained with LSK antibodies as described. Additional staining with FITC-conjugated
Annexin V (BD Pharmingen) and 7-AAD (BD Pharmingen) enabled the identification of
apoptotic cells. Cells that stain positive for Annexin V and negative for 7-AAD are
undergoing apoptosis (Vermes et al., 1995). Three independent experiments were
performed using each strain for each treatment (0 versus 2 Gy radiation), with at least two
mice for each experiment. Flow cytometric analysis was performed on a triple laser
FACSVantage flow cytometer (Becton-Dickinson).
Serial Transplantation Assay to Measure HSC Self-Renewal
Young B6 and congenic mice were irradiated with 0, 1, or 2 Gy of gamma
radiation (whole body) from a 137Cs source Mark 1 Irradiator (J.L. Shepherd and
Associates) at a dose rate of 1.73 Gy per minute three days prior to sacrifice. Whole
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bone marrow cells were isolated from young B6 and congenic mice as described above.
These cells (CD45.2) served as “test” cells for individual transplantation assays. Equal
numbers (1x106) of test cells were admixed with CD45.1 competitor cells and injected
into lethally irradiated (9 Gy) CD45.1 primary recipients. Marrow was harvested from
the primary recipients 20 weeks post transplant and injected into secondary recipients.
An identical regimen was repeated once more. At each transplant, peripheral blood,
whole bone marrow, Lin-, and LSK cells were analyzed. For peripheral blood anaylsis,
mice were bled from the retroorbital sinus under isofluorane anesthesia prior to
sacrificing by CO2 asphyxiation. Erythrocytes were depleted by hypotonic lysis and
leukocytes were stained with FITC-conjugated monoclonal anti-CD45.2 (clone ALI4A2)
and PE-conjugated monoclonal antibodies (Pharmingen) specific for B (antiCD45R/B220; clone RA36B2) and T lymphocytes (anti-Thy1.2; clone 30H12) or
granulocytes (anti-Ly6G/Gr-1; clone RB6-8C5) and macrophages (anti-CD11b/Mac-1;
clone M1/70). Cells were analyzed using a FACScan flow cytometer (BectonDickinson). Bone marrow Lin- and LSK cells were stained and analyzed as described
above. The self-renewal capacity was determined by comparing the percentage of B6 and
congenic derived CD45.2+ cells in recipients at each round of transplantation.
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Results
CD150+ CD48- Cells in Congenic Mice
In order to ensure that the HSC aging phenotype is observed in functionally equivalent
cell populations, we measured the number of CD150+ CD48- cells in the bone marrow of
young and old B6 and congenic mice. As expected, at a young age, I found no significant
difference (P > 0.05) in the number of CD150+ CD48- cells per 2 femora and 2 tibiae
between B6 and congenic mice (38 x 103 ± 8 x 103 cells per mouse and 23 x 103 ± 9 x 103
cells per mouse, respectively). However, in old mice, replacement of the B6 alleles at the
QTL with D2 alleles in the congenic interval caused a significant decrease in the absolute
number of CD150+ CD48- cells per 2 femora and 2 tibiae. Old B6 mice contained 103 x
103 (± 14 x 103) CD150+ CD48- cells per 2 femora and 2 tibiae whereas old congenic
mice contained 59 x 103 (± 8 x 103) CD150+ CD48- cells per 2 femora and 2 tibiae, a
43% decrease (P ≤ 0.05) (Figure 2.2A). Moreover, on the basis of frequency, light
density marrow from old B6 mice contained 0.25% ± (0.03%) CD150+ CD48- cells, 39%
more than that for old congenic mice (0.18% (±0.01%) (P ≤ 0.01) (Figure 2.2B). The fact
that the absolute number of CD150+ CD48- cells increased in old congenic mice
compared to young probably reflects the fact that regulation of stem cell aging is a
complex quantitative trait that is controlled by multiple loci, in addition to the
chromosome 2 QTL, and that body size increases ~50% from 2 months to 2 years.
Therefore old congenic mice display an intermediate phenotype when compared to old
B6 and D2 mice.
Cell Cycle Analyses
Cell cycling has the ability to influence HSC numbers in two ways; 1) increases
or decreases in the number of actively cycling cells can either increase or decrease the
total number of HSCs, and 2) increases or decreases in the time it takes to proceed
through the cell cycle can subsequently increase or decrease HSC numbers. However,
even though increased stem cell cycling has the potential to increase HSC numbers,
exhaustion of HSC self-renewal potential, resulting in terminal differentiation or
senescence, is an inevitable outcome of a large number of cellular divisions. Additional
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studies suggest that engraftment efficiency may be correlated with different phases of the
cell cycle. Decreased engraftment potential was observed when HSCs were progressing
through S/G2/M phases of the cell cycle, thus suggesting that active cycling negatively
correlates with engraftment potential (Bowie et al., 2006; Dykstra and de Haan, 2008;
Fleming et al., 1993; Habibian et al., 1998; Vermes et al., 1995). Having previously
shown that congenic mice are severely compromised after 2 Gy of irradiation in a
transplant setting, I hypothesized that there would be an increase in the number of
congenic HSCs in S phase following irradiation, and that this increase in cycling would
cause replicative exhaustion of their stem cell pool, and perhaps explain why they cannot
sustain hematopoiesis in a competitive transplant setting. Increased cell cycling after a
stressor such as irradiaton, may also be indicative of the cells inability to activate
appropriate cell cycle checkpoints. This hypothesis can also be extended to old congenic
mice, in that increased cell cycling in old HSCs (or throughout the lifespan of the
organism) would lead to exhaustion of the stem cell pool as well as decrease engraftment
potential in a competitive transplant setting. In order to address the role of the
chromosome 2 QTL in HSC cell cycle kinetics, I measured the proportion of HSCs in S
phase of the cell cycle using the BrdU incorporation assay (Dolbeare et al., 1990).
Young B6 and congenic mice were given 2 Gy of irradiation and the percent of cells in S
phase in whole bone marrow, Lin-, and LSK cells were measured at 0h, 6h, 16h, 3d, and
7d following irradiation (Figure 2.3A). I found no significant difference in the
percentage of cells in S phase in whole bone marrow, Lin- and LSK cells between young
B6 and congenic mice under steady-state conditions (no irradiation), as well as at all time
points tested following 2 Gy of irradiation (Figure 2.3B). Congenic cells, like B6 cells
were able to respond appropriately to stress by increasing cell proliferation in all cell
populations. Approximately 4-5% of LSK cells (in both strains) stained positive for
BrdU 1 hour following in vivo intraperitoneal injection (Figure 2.4A). As expected,
almost 90% of LSK cells were in G0/G1 phase of the cell cycle under steady-state
conditions, indicated by the lack of BrdU staining as well as by having a diploid content
of DNA (Figure 2.4B). Six hours following irradiation, I observed a slight but nonsignificant decrease in the percent of B6 LSK cells in S phase compared to an increase in
congenic LSK cells (Figure 2.4A). Sixteen hours post irradiation the percent of LSK
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cells in S phase in both strains increased, with a concurrent decrease in the percent of
LSK cells in G0/G1 phase, again demonstrating that the congenic LSK cells do not have
a proliferation defect (Figure 2.4A and B). As with B6 cells, congenic LSK cells
remained in a high state of proliferation at least one week following irradiation, while the
percent of cells in G0/G1 remained low in comparison to steady state levels. This inverse
relationship in the percent of LSK cells in S phase and percent of cells in G0/G1
illustrates how the poised LSK cells are activated to enter the cell cycle after stress in
order to replace the differentiated cells that were eliminated. Interestingly, six hours post
irradiation we observed a large, but non-significant, increase in the percent of B6 cells in
G2/M phase of the cell cycle compared to congenic cells (Figure 2.4C). This increase
was transient, as by sixteen hours post irradiation the percent of B6 cells in G2/M
returned to almost steady-state levels. Three days post irradiation treatment, we saw no
significant difference in the percent of LSK cells in G2/M between B6 and congenic
mice. However, seven days after treatment, the percent of LSK cells in G2/M in
congenic mice returned to steady-state levels, whereas the percent of LSK cells in G2/M
in B6 mice remained elevated compared to pre-treatment levels (Figure 2.4C).
Apoptosis Analyses
Numerous studies have shown that apoptosis plays an important role in maintaining HSC
homeostasis (Janzen et al., 2006; Opferman et al., 2005; Rodrigues et al., 2005), yet few
have addressed the involvement of apoptosis in the aged hematopoietic system. As stem
cells age, they accumulate increasing amounts of macromolecular and DNA damage
likely due to the replicative stress that occurs over the long lifespan of the cell.
Damaged cells in the aged HSC compartment undergo apoptosis in order to rid the pool
of dysfunctional cells that would then give rise to damaged progeny or would perhaps
become tumorigenic. The same ensues when the cells are exposed to stressors, such as
low-dose radiation or chemotherapeutic drugs. Thus, we addressed the question of
whether or not congenic HSCs undergo higher levels of apoptosis compared to B6 HSCs,
perhaps contributing to the decreased number of stem cells as the mice age. To
determine whether D2 alleles in the QTL influence the apoptotic response in irradiated
congenic animals, we assessed annexin V staining of whole bone marrow, Lin-, and LSK
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cells (Figure 2.5A). Young (2-4 months) B6 and congenic mice were given 0 or 2 Gy of
irradiation and after two hours the mice were sacrificed and their bone marrow cells were
analyzed for apoptosis. We found no significant differences in annexin V staining in
whole bone marrow, Lin-, and LSK cells between B6 (3.9% ± 2.4%, 4.5% ± 1.0%, 4.14
± 2.1%, respectively) and congenic (2.9% ± 3.1%, 2.9% ± 2.0%, 2.1% ± 2.2%,
respectively) mice under steady-state conditions (no radiation) (Figure 2.5B). Similarly,
we found no significant variation in annexin V staining in whole bone marrow and LSK
cells from B6 (8.7% ± 4.1% and 8.2% ± 6.6%, respectively) and congenic (4.0% ± 2.4%
and 13.9% ± 5.0%, respectively) mice 2 hours post 2 Gy of irradiation. However, in the
Lin- cell population, we observed a significant (~ 3 fold) increase (P = 0.01) in annexin V
staining in B6 (34.7% ± 3.2%) mice post irradiation treatment compared to congenic
(12.4% ± 8.6%) animals. We also observed increases in Annexin V staining in all cell
populations tested except congenic whole bone marrow cells post 2 Gy of irradiation.
Self Renewal Analyses
A signature feature of stem cells is their ability to undergo self-renewing
divisions, an attribute that is best tested by the serial transplantation of bone marrow cells
through a series of lethally irradiated recipients. We therefore tested the self-renewal
capacity of congenic HSCs in serial transplantation experiments in order to determine
whether the difference in HSC numbers in old congenic and B6 mice was due to
decreased self-renewal capacity of the congenic cells. One or 2 Gy of irradiation was
administered to young (2 months) B6 and congenic mice, which we hypothesized would
cause significant replicative stress, thus creating an “aged” stem cell population. We
chose to irradiate cells with 1 Gy in addition to 2 in hopes of identifying an intermediate
phenotype. After 3 days, the mice were sacrificed and their bone marrow cells were
harvested and transplanted into lethally (9.0 Gy) irradiated CD45.1 recipients along with
and equal number of CD45.1 competitor cells (Figure 2.6). Twenty weeks post
transplant, the primary recipients were sacrificed and their bone marrow cells were
harvested and injected into lethally irradiated secondary recipients without the addition of
competitor cells, and such serial transplantation was continued once more. At each
transplant, the peripheral blood and bone marrow of the primary, secondary, and tertiary
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recipients were analyzed by staining the cells with antibodies directed against CD45.1,
CD45.2, c-kit, sca-1, as well as the Lin- cocktail described above, therefore allowing us
to examine the percentage of donor derived cells (CD45.2) in the stem (LSK) and
progenitor (Lin-) compartments. Greater self-renewal capacity of HSCs from one strain
relative to the other is reflected by the percentage of donor derived cells (either B6 or
congeic). In primary, secondary, and tertiary recipients, we saw no significant difference
in the percentage of CD45.2+ cells between B6 and congenic mice given no irradiation in
peripheral blood as well as in the bone marrow nucleated cells (Figure 2.7). In contrast,
in recipient mice injected with cells receiving 2 Gy of irradiation, we observed
significantly less CD45.2+ congenic cells in primary recipient bone marrow cells and in
secondary and tertiary recipient peripheral blood and bone marrow cells (Figure 2.7).
Further, contribution to mature peripheral blood cell lineages (macrophages/granulocytes,
B cells, and T cells) from congenic mice subject to 2 Gy of irradiation was compromised
compared to similarly treated B6 mice in all three recipient groups (Figure 2.8). Thus,
serial transplantation of bone marrow cells demonstrates that 2 Gy of irradiation imparts
a stress that severely compromises the self-renewal capacity of congenic cells compared
to B6 cells, and that this decline in cellular function is intrinsic to the stem cells.
Surprisingly, in recipient mice injected with cells receiving 1 Gy of irradiation, I
observed significantly more CD45.2+ congenic cells in secondary recipient peripheral
blood and bone marrow compared to CD45.2+ B6 cells (Figure 2.7). Similarly, I also
observed higher contribution to all mature peripheral blood cell lineages in secondary
recipients that received cells from congenic mice irradiated with 1 Gy compared to
recipients that received cells from B6 mice irradiated with 1 Gy (Figure 2.8). However,
despite contributing ~50% to overall CD45.2 chimerism, the percentage of LSK cells
derived from congenic mice treated with 1 Gy of irradiation was significantly lower in
secondary recipients compared to LSK cells derived from similarly treated B6 mice. This
indicates that LSK cells derived from congenic mice treated with 1 Gy of irradiation may
differentiate rather than self-renew after the irradiation insult, which is reflected in the
large number of differentiated cells but lack of LSK cells in secondary and tertiary
recipient mice.
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Discussion
HSCs from young congenic mice display no apparent hematopoietic defects
compared to HSCs from young B6 mice, whereas old congenic stem cells display overt
signs of aging. However, using a surrogate aging assay, we found that we could uncover
hematopoietic defects in young congenic mice simply by treating them with irradiation,
which causes significant DNA damage in the stem cell pool. However, it remains to be
determined why old and irradiated congenic HSCs are functionally compromised
compared to age matched or similarly treated B6 HSCs. I therefore measured the
proliferative, apoptotic, and self-renewal capabilities of young congenic mice treated with
2 Gy of irradiation. The unavailability of large numbers of old congenic mice prevented
the same analyses from being carried out in these animals. Although low dose irradiation
does not precisely mimic the aging process, it does elicit a measurable phenotypic
response in the congenic mice, which we hypothesize will be recapitulated in old mice as
well.
I first showed that while there is no difference in the number of CD150+ CD48cells between young B6 and congenic mice, old congenic mice have significantly fewer
CD150+ CD48- cells compared to old B6 mice. This finding is important for two
reasons; (1) it demonstrates that the difference in stem cell number in aged mice can be
extended to highly purified primitive stem cell populations, and (2) it excludes the
possibility of measuring the frequency of contaminating, non-HSCs in old mice, and
ensures that we are analyzing the phenotype in functionally similar cells populations.
The fact that I did not detect variation in the frequency of young stem cells demonstrates
that D2 alleles at other loci are responsible for this variation. It is not practical to obtain
enough CD150+ CD48- cells for use in mechanistic studies due to the fact they make up
such a small percentage of the total bone marrow population. Therefore in my studies I
rely on the absence of lineage markers and the presence of Sca-1 and c-kit (LSK cells) to
denote a population enriched in primitive HSCs. CD150+ CD48- cells and LSK cells
display similar levels of long-term multilineage reconstitution potential, therefore I feel
that the use of LSK cells represents the best possible cell population in which to study
HSC properties.
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In order to measure the proportion of HSCs in S phase of the cell cycle at various
time points following 2 Gy of irradiation, I performed in vivo BrdU labeling studies.
Consistent with published data, approximately 4-5% of LSK cells stained positive for
BrdU 1 hour following in vivo intraperitoneal injection, and no significant differences
were observed between B6 and congenic mice under steady-state conditions (no
irradiation) (Cheshier et al., 1999; Morrison et al., 1995). As expected almost 90% of
LSK cells were in G0/G1 phase of the cell cycle under steady-state conditions, indicated
by the lack of BrdU staining as well as by having a diploid content of DNA. Although all
HSCs cycle regularly, this method only measures the fraction of HSCs replicating their
DNA during a one hour pulse of BrdU, which explains why only a small fraction of
HSCs were found to be in S phase. Nonetheless, this finding is consistent with the idea
that a small number of HSCs are always dividing in order to maintain steady-state
hematopoiesis.
I chose to look at the fraction of cells in S phase at various time points following
irradiation in order to determine how hematopoietic cells from B6 and congenic mice
respond (in terms of cell cycle kinetics) to stress. At all time points following irradiation,
I observed no significant difference in the percentage of WBM, Lin-, and LSK cells in S
phase between the two mouse strains, thus presumably excluding the possibility that
congenic and B6 hematopoietic cells exhibit differences in cell cycle kinetics following
irradiation. In contrast to WBM and Lin- cell populations, the percentage of LSK cells in
S phase in both strains remain elevated by 2- to 3- fold at least 7 days following
irradiation. Although no significant differences between the percentage of HSCs in S
phase were observed, a higher percentage of congenic LSK cells stained positive for
BrdU compared to B6 cells prior to and at all time points following irradiation. This
slightly higher cycling activity could potentially result in earlier exhaustion of the
congenic HSC pool and contribute to the decreased competitiveness seen in
transplantation assays. Moreover, the subtle increase in congenic LSK cycling may be
indicative of their inability to activate cell cycle checkpoints in response to cellular
stressors. In this scenario, congenic LSK cells may accumulate DNA damage, which
over time could lead to functional defects in their stem cell population. If cell cycle
checkpoint control were compromised throughout the lifespan of an organism, the stem
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cell pool would eventually become cluttered with damaged cells, ultimately resulting in
an overall decline in function in this cell population with age.
Next, I analyzed the percentage of cells undergoing apoptosis in the bone
marrow compartment of B6 and congenic mice exposed to irradiation. Presumably,
increased levels of apoptosis in congenic LSK cells could contribute to the decreased
numbers of stem cells observed in old mice as well as contribute to the irradiation
sensitivity phenotype of congenic LSK cells if they undergo apoptosis after irradiation
exposure. Surprisingly, I was unable to detect any profound differences in percentages of
WBM and LSK cells undergoing apoptosis between B6 and congenic mice. In both
strains, we found that a higher percentage of Lin- cells were undergoing apoptosis
compared to LSK cells. This finding is in agreement with other studies, which suggest
that progenitor cell populations are more prone to apoptosis compared to more quiescent
stem cells (Niedernhofer, 2008; Park and Gerson, 2005; Reya et al., 2001). However, I
found that B6 Lin- cells undergo significantly more apoptosis than do congenic Lin- cells
after 2 Gy of irradiation. This finding was unexpected, as I hypothesized that increased
apoptosis would correlate with decreased HSC functionality. However, the higher
percentage of B6 Lin- cells undergoing apoptosis compared to congenic Lin- cells
following irradiation may have several causes. First, the higher percentage of apoptosis
in the B6 Lin- population supports the idea that B6 cells have a heightened DNA damage
response compared to congenic cells. Following cellular damage, B6 progenitor cells
may be able to activate checkpoint responses more efficiently than congenic cells, thus
enabling them to either repair DNA damage or undergo apoptosis. This in turn would
protect the B6 hematopoietic compartment from giving rise to cells with damaged DNA,
and thus ultimately protect the long-term function of this cell population. This scenario is
consistent with our cell cycle data: congenic cells continue to cycle even when exposed to
DNA damaging events instead of activating cell cycle checkpoints or undergoing
apoptosis. Inappropriate activation of cell cycle checkpoints and/or induction of apoptosis
in response to stress would cause the congenic HSC pool to accumulate damaged cells.
These damaged cells may eventually undergo growth arrest and/or become senescent, and
thus ultimately contribute to the decreased function the congenic hematopoietic system in
aged mice. Indeed, several recent papers indicate that DNA damage accumulation in
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HSCs results in a decline in their cellular function (Niedernhofer, 2008; Nijnik et al.,
2007; Rossi et al., 2007). I hypothesize that altered cell cycle checkpoint control,
resulting in improper cell cycle exit and induction of apoptosis, leads to extensive DNA
damage accumulation in congenic Lin- and LSK cells, and thus likely contributes to age
associated hematopoietic defects.
Another contributing factor to increased B6 Lin- apoptosis after irradiation is the
increased transcript expression of BCL2-like 11, as was later revealed by our microarray
analyses. BCL2-like 11, also referred to as Bim, is a BH3-only protein member of the
Bcl-2 family of proteins (O'Connor et al., 1998). Bim acts as an apoptosis facilitator and
has been shown to play an important role in the apoptosis of early hematopoietic
progenitors (Kuribara et al., 2004).
Hematopoietic homeostasis relies on the presence of a functional HSC pool which
is maintained throughout the life time of an animal by self renewing stem cell divisions.
Given that the primary role of adult stem cells is to replenish aged and functionally
impaired tissues, this self-renewal capacity must be maintained during the aging process
in order to ensure maximal longevity. In order to determine the effects of the
chromosome 2 QTL on HSC self-renewal, I performed serial transplantation experiments,
which serve as the most stringent test of HSC potential. I hypothesized that congenic
mice exposed to 2 Gy of irradiation (and by extension aged mice as well) would display a
stem cell self-renewal defect compared to B6 mice. Defects in self-renewal ability would
provide a mechanistic basis as to why the number of congenic HSCs declines during
normal aging.
As expected, under steady state conditions (no irradiation), I saw no significant
difference in the percentage of CD45.2+ cells from B6 and congenic mice in peripheral
blood and bone marrow nucleated cells in all three groups of recipients (Figure 2.7).
However, when analyzing the hematopoietic compartment of recipients that received
cells irradiated with 2 Gy, I found significantly fewer congenic CD45.2+ cells in the bone
marrow of primary, secondary, and tertiary recipients as well as in the peripheral blood of
secondary and tertiary recipients 20 weeks post-transplant compared to B6 CD45.2+
cells. Having determined that there is no dramatic difference in the proliferation rate of
B6 and congenic HSCs, I next determined whether or not there was a difference in the

49

number of B6 or congenic derived LSK cells in the recipient mice, thus leading to the
competitive repopulation differences that we observed with each serial transplant.
Indeed, results from analyzing the bone marrow of recipient mice revealed that
significantly fewer LSK cells were derived from congenic cells treated with 2 Gy of
irradiation compared to B6 cells in secondary and tertiary recipients. Thus, the
competitive disadvantage of the congenic cells treated with 2 Gy of irradiation results
from a lower stem cell frequency in recipient mice. Virtually no LSK cells derived from
congenic cells treated with 2 Gy of irradiation were observed in secondary and tertiary
recipient mice, indicating that the replicative stress imparted after the first transplant
resulted in stem cell exhaustion. I hypothesize that the same scenario would ensue in
aged congenic LSK cells, in that they would have a severe self-renewal defect when
compared to old B6 LSK cells. Indeed, a decreased congenic self-renewal capacity may
explain the decrease in stem cell number in these mice during normal aging.
The fact that congenic cells treated with 1 Gy of irradiation contributed
significantly more to secondary recipient peripheral blood and bone marrow nucleated
cells than did similarly treated B6 cells was not expected. However, it may suggest that
B6 differentiated cells are sensitive to irradiation up to some threshold approaching 2 Gy,
after which they may activate DNA damage response and repair pathways. Indeed, I
observed that B6 Lin- cells undergo significantly more apoptosis after 2 Gy of irradiation
compared to congenic cells. Apoptosis may be the mechanism by which they purge their
hematopoietic compartment, thus preserving the self-renewal capacity and ensuring
maintenance of a high quality HSC pool over time. It may also suggest that congenic
LSK cells chose to differentiate rather than self-renew after 1 Gy of irradiation. This
scenario would explain why we observed high contribution to overall CD45.2 chimerism
and mature blood cells, but a very low percentage of LSK cells in all recipient groups
injected with congenic cells. After 2 Gy of irradiation the congenics have already
exhausted their LSK pool, thus explaining why I observed virtually no LSK cells as well
as differentiated cells in secondary and tertiary recipients. The B6 cells, on the other
hand preserve their may LSK pool after 1 Gy at the expense of producing differentiated
cells. By the time that they are hit with 2 Gy of irradiation they have enough LSK cells
to both maintain the pool as well as differentiate into mature blood cells. Therefore, at
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least in B6 and our congenic mice, it is vital to preserve a primitive stem cell pool when
faced with cellular stressors, at the expense of differentiated cells, in order to survive the
insult. Additionally, the fact that the B6 cells treated with 1 Gy of irradiation
reconstituted tertiary recipients as well as congenic cells, suggests that the preservation of
their LSK pool in secondary recipients was sufficient to rescue their hematopoietic defect
observed in secondary recipients. It is possible however that the LSK cells under these
conditions (irradiation as well as serial transplant) have lost fidelity of the markers used
to identify them. In this scenario, the LSK cells present in B6 mice after 1 Gy may not be
functionally similar to LSK cells under normal conditions. This may explain why both
B6 and congenic cells were able to contribute equally to peripheral blood chimerism in
tertiary recipients, even though 1 Gy of irradiation apparently eradicated the congenic
LSK cells in secondary recipients.
In sum, I demonstrated that D2 alleles in the chromosome 2 QTL reduce the
number of CD150+ CD48- cells in old mice compared to B6 alleles. In addition, D2
alleles in the QTL blunt the ability to purge damaged Lin- cells after exposure to 2 Gy of
irradiation as well as abolish the repopulating capacity, and hence self-renewal, of
congenic cells exposed to 2 Gy of irradiation. I hypothesize that old cells would perform
similar to irradiated cells in cell cycle, apoptosis, and self-renewal assays, and am
currently testing this hypothesis using aged congenic mice.
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Figure 2.1 Cellular fate decisions of stem cells.
There are four possible cell fate decisions for stem cells: 1) a stem cell may remain
quiescent and not divide at all; 2) a stem cell may undergo symmetric cell divisions to
generate two new self-renewing stem cells or two new differentiated progeny; 3) a stem
cell may undergo asymmetric cell divisions and give rise to one new stem cell and one
differentiated cell; and 4) a stem cell may undergo apoptosis and no longer contribute to
hematopoiesis. SC = stem cell, P = progenitor cell.
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Figure 2.2 The number of CD150+ CD48- cells per 2 femora and 2 tibiae in
young and old B6 and congenic mice as determined by flow cytometry. At a
young age, there is no significant difference in the number of CD150+ CD48- cells
between B6 and congenic mice. As the mice age, B6 mice accumulate significantly
more CD150+ CD48- cells per 2 femora and 2 tibiae than do congenic mice (A).
Results are given as mean ± SEM (n ≥ 5 mice, three replicate experiments).
Representative dot plots of bone marrow cells showing the percentage of CD150+
CD48- cells in old congenic and B6 mice (B). Old congenic mice have significantly
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less CD150+ CD48- cells compared to old B6 mice. On average B6 mice have a
higher percentage of CD150+ CD48- cells (0.25% ± 0.03%) compared to old
congenic mice (0.18% ± 0.01%) (P ≤ 0.01). The plots represent one experiment
where 3-4 mice were pooled. † indicates statistical significance for comparison of old
B6 and congenic cells (P ≤ 0.05). * indicates statistical significance for intra-strain
comparison of cells as a function of age (P ≤ 0.05). Results are given as mean ±
SEM.
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Figure 2.3 Analysis of cell cycling in three hematopoietic cell populations following
irradiation treatment. Schematic representing the time scheme used for irradiation
treatment (A). Irradiation was administered to B6 and congenic mice 6 hrs, 16 hrs, 3
days, and 7 days prior to sacrifice. One hour before the mice were sacrificed, 150 mg per
kg of body weight of 5-flurouracil was intraperitoneally injected into the mice. I
observed no significant difference in the percentage of cells in S-phase (BrdU+) between
B6 and congenic WBM, Lin-, and LSK cells at all time points tested following irradiation
treatment (P > 0.05) (B). Three replicate experiments were performed using 3-5 mice per
strain for experiments. The pooled results are given as mean ± SEM.
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Figure 2.4 Profiles of the percent of LSK cells in various phases of the cell cycle
following irradiation treatment. Percent of LSK cells in S phase of the cell cycle prior
to (0 hr) and at several time points following irradiation (A). Approximately 4-5% of
LSK cells (in both strains) were in S phase under steady-state conditions, however this
percentage increased at various timepoints following irradiation. A higher percentage of
congenic LSK cells stained positive for BrdU at all time points tested. Approximately
90% of LSK cells were in G0/G1 phase of the cell cycle under steady-state conditions,
however this percentage decreased in both strains following irradiation (B). Six hours
post irradiation we observed a large, but non-significant, increase in the percent of B6
cells in G2/M phase of the cell cycle compared to congenic cells (C). This increase was
transient, as by sixteen hours post irradiation the percent of B6 cells in G2/M returned to
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almost steady-state levels. Seven days after treatment, the percent of LSK cells in G2/M
in B6 mice remained elevated compared to the percent of LSK cells in G2/M in congenic
mice (C).
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Figure 2.5 Identification of Annexin V positive/7AAD negative apoptotic HSCs.
Cells were stained with a lineage cocktail and a gate was set to identify Lin- cells.
Further gates were set to detect sca-1+ and c-kit+ cells. The resulting Lin- sca-1+ c-kit+
(LSK) cells were then analyzed for Annexin V and 7AAD staining. Flow cytometry
plots are from one representative animal (A). No differences in the percentage of
apoptoic cells between B6 and congenic mice exist under steady state conditions (B). A
significant increase in apoptosis was observed in the B6 Lin- population post 2 Gy of
irradiation compared to congenics (B). † indicates statistical significance for comparison
of B6 Lin- cells before and after irradiation (P ≤ 0.01). * indicates statistical
significance for comparison of B6 and congenic Lin- cells after irradiation (P = 0.01).
Results are given as mean ± SEM (n ≥ 2 mice, three replicate experiments).
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(unirradiated)

Figure 2.6 Self-renewal analysis of B6 and congenic HSCs pre- and post irradiation
treatment. B6 and chromosome 2 congenic mice were subject to 0, 1 or 2 Gy of
irradiation and after 3 days bone marrow was harvested and injected in lethally irradiated
primary recipients. After 20 weeks, primary recipients were sacrificed and harvested
bone marrow was injected to secondary recipients. This regimen was repeated once
more. At each transplant, the peripheral blood and bone marrow of the primary,
secondary, and tertiary recipients were analyzed. n = 4-5 mice for each recipient group.
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Figure 2.7 Self-renewal analysis of HSC in serial bone marrow transplantation.

B6 and congenic derived peripheral blood leukocytes and bone marrow nucleated
cells treated with various doses of irradiation were analyzed 20 weeks after they
were transplanted into primary, secondary, tertiary recipients. Each data point
represents the mean for groups of mice (P ≤ 0.05).
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Figure 2.8 B6 and congenic contribution to mature blood cell lineages during serial
transplantation. B6 and congenic derived B cells, T cells, and

macrophage/granulocyte cells treated with various doses of irradiation were
analyzed 20 weeks after they were transplanted into primary, secondary, tertiary
recipients. Each data point represents the mean for groups of mice (P ≤ 0.05).
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CHAPTER THREE
Microarray analysis and identification of candidate quantitative trait genes that
regulate the HSC aging phenotype
Summary
In order to identify the candidate gene(s) located within the chromosome 2 QTL
that regulate the differential HSC aging and/or the differential radiation sensitivity
phenotypes of B6 and congenic mice, microarray gene chip studies were performed. I
measured the expression profiles of young and old B6 and congenic lineage- (Lin-) cells
prior to and post treatment with 2 Gy of total body radiation using Affymetrix M430
microarray chips. Stringent statistical anaylses revealed that a total of 90 genes located
within the chromosome 2 QTL were differentially expressed between the B6 and
congenic mice. Next, using the WebQTL database, I found that 6 of the 90 differentially
expressed genes located within the QTL were cis-regulated and therefore served as the
best possible candidate genes for regulating the HSC traits. Of the 6 cis-regulated genes,
I chose to confirm the differential expression of Retinoblastoma like protein 1 (p107) and
Sorting nexin 5 (Snx5) due to their previous involvement in hematopoiesis and/or stem
cell biology. Real time PCR in stem (LSK) and progenitor (Lin-) cell populations
validated the differential expression of both genes. Snx5 mRNA was found to be
elevated in young and old Lin- and LSK cells and p107 mRNA was found to be elevated
in young and old Lin- cells and in old LSK cells. These results demonstrate that B6
alleles in the chromosome 2 QTL up-regulate the expression of both Snx5 and p107 and
suggest that these genes are positive regulators of HSC number and therefore may
regulate the HSC aging and/or radiation sensitivity phenotypes.
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Introduction
Stem cells are indispensable entities in most multicellular organisms in that they
are responsible for forming tissues during early development and maintaining them in the
adult. This property places stem cells at the forefront of both developmental biology and
regenerative medicine. But what defines a stem cell and provides them with their unique
properties? With the development of tools for global gene expression analyses over the
past several years, researchers have attempted to answer this question by identifying a
universal stem cell gene expression signature. In 2002, two groups independently
attempted to identify a so-called “stemness” signature by analyzing the expression
profiles of mouse embryonic stem cells (ESCs), HSCs, and neural stem cells (NSCs)
(Ivanova et al., 2002; Ramalho-Santos et al., 2002). Both studies yielded a list of ~200
stem cell specific genes that mouse ESCs, HSCs, and NSCs commonly expressed, but
rather surprisingly, the results of the two studies showed minimal overlap.
Approximately a year later, a third expression profiling study comparing ESCs, NSCs,
and retinal progenitor/stem cells failed to uncover a unique stem cell fingerprint, with
only one gene (Itga-6) being commonly identified among the three studies (Fortunel et
al., 2003). It is possible that the lack of overlap between the stem cell profiles identified
in these studies was due to different experimental approaches. Another possibility is that
different stem cell types may use different gene networks to achieve self-renewal or
multipotency, thus a universal stemness signature does not exist and cross tissue
comparative expression analyses are not useful in identifying stem cell specific genes.
Perhaps a better way to determine a stemness profile is to compare the
transcriptional profile of specific stem cells with that of their differentiated progeny.
Chambers et al. recently performed this type of analysis by comparing the transcriptional
profiles of HSCs, erythroid cells, granulocytes, macrophages, monocytes, natural killer
cells, T cells, and B cells (Chambers et al., 2007a). Although this expression database
provided lists of genes exclusively expressed in specific hematopoietic cell types, the
long list of HSC specific genes still makes it difficult to determine their individual and/or
combined roles in stem cell function.

Thus it is necessary to combine expression
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profiling with other genetic approaches in order to identify important HSC regulatory
genes.
As mentioned previously, many hematopoietic traits are genetically controlled
since they differ between various strains of inbred laboratory mice. Due to the numerous
hematopoietic differences that exist between B6 and D2 mice and the existence of BXD
recombinant inbred (RI) mouse strains, we and others have identified numerous genomic
regions (QTLs) affecting HSC traits (de Haan et al., 1997; de Haan and Van Zant, 1999;
Muller-Sieburg and Riblet, 1996). However, a major limitation of traditional QTL
mapping approaches using RI reference panels is that they can only identify genomic
regions of interest, often containing many genes. It is hypothesized that polymorphic
variants, often in the form of single nucleotide polymorphisms (SNPs), underlie
phenotypic differences. Since there are thousands upon thousands of SNPs in any one
QTL region, and often multiple SNPs in any one gene, it is a daunting task to identify the
polymorphism and therefore the gene that underlies a specific trait. Thus it seems that
strategies aimed at identifying important stem cell genes using expression profiling or
genetic linkage analysis alone have proven to be difficult. However, the combination of
gene expression studies with genetic linkage analyses offers a promising approach for
identifying specific genes that underlie HSC traits.
In the present study, I performed genome wide gene expression analyses using a
cell population enriched in stem and progenitor cells in order to identify genes located in
the chromosome 2 QTL that influence HSC aging. DNA microarrays were used to
identify genes that are differentially expressed between chromosome 2 congenic and B6
background mice at young and old ages as well as after irradiation treatment. Although
this approach makes the assumption that transcriptional regulation underlies the
polymorphism, a significant proportion of the QTL that have been experimentally solved
with QT gene identification to date have used this approach (Aitman et al., 1999; Flint et
al., 2005; Karp et al., 2000; Klein et al., 2004; McBride et al., 2003; Rozzo et al., 2001).
The congenic mouse model is a vital component in performing this type of experiment.
Because the congenic animals have a genome that is approximately 99% B6 with the
exception of the introgressed D2 interval, comparison of the number of differentially
expressed genes between the two strains is greatly reduced compared to the number of
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differentially expressed genes between D2 and B6 strains. This simplifies the process of
identifying potential candidate genes that are responsible for the phenotype of interest.
Another approach that combines genetics with gene expression analyses involves
profiling gene expression patterns (using Affymetrix arrays) in recombinant inbred
strains of mice (Bystrykh et al., 2005; Chesler et al., 2005). The general idea is to treat
mRNA levels as traditional quantitative traits. This in turn allows you to detect and
characterize QTLs that are linked to the variation in gene expression of individual
transcripts. QTLs that are responsible for variation in expression of transcripts can be
classified into two groups: cis-acting QTLs which are located at the physical position of
the transcript itself, and trans-acting QTLs that modulate the expression of large numbers
of genes throughout the genome (Bystrykh et al., 2005). This approach has recently been
used to identify variation in gene expression patterns in HSCs isolated from the BXD RI
strains. This information is in a public database available at www.webqtl.org (Wang et
al., 2003). By searching for cis-regulated transcripts located in a QTL that controls a
particular trait, it is possible to identify potential candidate genes that control the trait.
Cis-regulated genes within QTLs represent the best candidate genes, as they may contain
polymorphisms that affect both their own expression level as well as the trait of interest.
Using the WebQTL database, it is possible to determine if differently expressed genes
(obtained from microarray analyses) are cis-regulated. I used this strategy to identify two
novel candidate regulators of HSC aging.
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Materials and Methods

Animals
Young (2-4 months) and old (24-25 months) C57BL/6 (B6) (Ptprcb [CD 45.2])
mice were purchased from the National Institute of Aging (NIA) Aged Mouse Colony at
Harlan Sprague Dawley (Indianapolis, IN) and were used as the background strain.
Chromosome 2 congenic mice, with a genetic interval from D2 mice spanning 50 Mbp
(130Mbp -180 Mbp) on the distal end of chromosome 2, were generated as described
previously (Geiger et al, 2005). Young (2-4 months) and aged (24-27 months) congenic
animals were used in the experiments. Genotypes of congenic animals were confirmed
by PCR screening of genetic markers flanking the congenic interval and located
throughout the genome. All mice were female and were housed in the Division of
Laboratory Animal Resources (DLAR) at the University of Kentucky Chandler Medical
Center and were maintained under pathogen-free conditions according to NIH guidelines
for animal welfare.
Immunofluorescent staining of cells and flow cytometry
Mice were euthanized by CO2 asphyxiation and the femora and tibiae were
removed to a Petri dish containing Hanks Balanced Salt Solution (HBSS, GIBCO)
supplemented with 2% fetal bovine serum (FBS, Invitrogen). Femora and tibiae were
flushed with 4 mL media to obtain a single cell suspension. Mononucleated cells were
obtained via Ficoll gradient separation and Fc receptors were subsequently blocked with
anti-CD16/32 (clone 2.4G2, Fc Block) to prevent non-specific staining. For Lineage
negative (Lin-) isolation, cells were identified by the lack of cell surface antigens
characteristic of cells committed to individual lineages of blood cell development. The
lineage cocktail consisted of the following antibodies: CD5 (clone 53-7.3) and CD8a
(clone 53-6.7) to identify T cells, CD45R/B220 (clone RA3-6B2) to identify B cells,
CD11b/Mac-1 (clone M1/70) and Ly-6G/Gr-1 (clone RB6-8C5) to identify macrophages,
and Ter119/Ly-76 (clone Ter-119) to identify erythrocytes. All antibodies were
biotinylated and were further stained with streptavidin-fluorescein isothiocyanate (SA68

FITC). Dead cells were excluded by propidium iodide (PI) staining. For Lin- Sca+ ckit+ (LSK) cells, light density bone marrow cells were stained with the above lineage
cocktail as well as stem cell specific cell surface markers, phycoerythrin (PE)-conjugated
Ly-6A/E (Sca-1; cloneE13-161.7) and allophycocyanin (APC)-conjugated CD117 (c-kit;
clone ne2B8). The LSK population is highly enriched in stem cells. Dead cells were
excluded by PI staining. All monoclonal antibodies were purchased from BD
Pharmingen. Cells were analyzed and sorted on a triple-laser FacsVantage (BectonDickinson) flow cytometer.
Total RNA isolation
For microarray analyses, total RNA was extracted from approximately 6x105 – 9x105
sorted Lin- cells using RNeasy Kit (Qiagen, Valencia CA). Cells were sorted from the
bone marrow of young (2-4 months) and old (24-25 months) B6 and congenic mice prior
to and post 2 Gy of irradiation administered from a 137Cs source Mark 1 Irradiator (J.L.
Shepherd and Associates) at a dose rate of 1.73 Gy per minute. Bone marrow cells were
harvested, labeled, and Lin- cells were isolated by cell sorting. RNA samples consisted
of cells pooled from at least 5 mice for each age, strain and treatment group. For
quantitative real time PCR analyses, RNA was extracted from either 1x105 or 2x105 LSK
and Lin- cells, respectively, using RNeasy kit (Qiagen, Valencia CA). Lin- and LSK
cells were sorted as described previously and all samples consisted of pooled cells from
at least 5 mice for each stain and age.
Microarray analysis of Lin- cells
RNA samples were hybridized according to Affymetrix protocols onto Murine Genome
430 2.0 arrays at the University of Kentucky Microarray Core Facility. Briefly, RNA
samples were reverse transcribed to cDNA, then cRNA was biotin-labeled, fragmented,
and hybridized to the array. Three biological samples per experimental group were
individually interrogated on separate Affymetrix M430 microarray chips resulting in a
total of 24 arrays. A 3-way ANOVA was used to analyze the results obtained from the
three replicate chips for each sample group. A statistical cutoff of P ≤ 0.01 was used and
we set no limits on fold-change. Two-way ANOVA’s were also performed to compare
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expression levels when considering any two of the three variables. Again, a statistical
cutoff was set at P ≤ 0.01 and no limits were set on fold change.
Quantitative real-time PCR
RNA samples from young (2-4 months) and old (24-25 months) B6 and congenic mice
were synthesized into cDNA by reverse transcription PCR. The 100 µl reaction mixture
consisted of sterile water, RNA, 10X RT buffer, MgCl2, deoxy NTPs, random hexamers,
RNase inhibitor, and MultiScribe reverse transcriptase. The cDNA samples were then
used for real time PCR to validate the differential expression of specific genes. cDNA
synthesis was performed as above using a 20 ul reaction mix. Taqman primers from
Applied Biosystems were used according to manufacturer’s instructions for each real
time PCR reaction. Due to the fact that GAPDH expression changes with age in B6 and
the congenic mice, the values obtained for the test gene were not normalized in Lin- and
LSK cells. Rather, equivalent numbers of cells were used in each experiment. We
initially normalized gene expression to cDNA content, but found that it wasn’t necessary
since similar values were obtained with non-normalized cDNA. Samples for the
derivation of standard curves and no-template controls were run in duplicate and
experimental cDNA samples were run in quadruplicate using an ABI PRISM 7700
Sequence Detector (PE Biosystems). Each biological sample consisted of pooled cells
from at least 5 mice and three replicate biological experiments were performed for each
age and strain.

70

Results
Identification of differentially expressed genes in chromosome 2 QTL by microarray
analysis
I investigated the possibility that transcriptional differences between congenic and B6
Lin- cells could point to candidate genes in the chromosome 2 QTL that contribute to two
phenotypic polymorphisms that exist between the strains: HSC aging as well as
sensitivity to low dose irradiation. Because the QTL congenic interval spans 50 Mb on
chromosome 2, merging our linkage analysis with expressing profiling studies seemed to
be a logical scientific approach to identify candidate genes that regulate the HSC
phenotypes. Three variables were examined: (a) the effect of strain—congenic vs.
background (in which only approximately 1% of the genome was different); (b) the effect
of age (2 months vs. 20+ months); and (c) the effects of 2 Gy of irradiation to compare
our surrogate assay to natural aging (Figure 3.1). Using a total of 24 Affymetrix 430 2.0
chips in three replicate experiments, a total of 1,630 probes had a significant three-way
interaction, i.e. the effect of one variable (strain) was dependent on the remaining two
variables (age and treatment). Another 1,922 probes were found to have significant twoway interactions, and finally 3,279 probes were found to have what we refer to as a
“significant main effect” (Figure 3.2). That is, the differential expression of the probe
was due independently to age, treatment, or stain. Perhaps, not surprisingly, of the 3,279
significant main effect probes, 1,215 had a significant age effect, 2,835 had a significant
treatment effect, and only 725 probes had a significant strain effect. In agreement with
our hypothesis that irradiation, in this context, mimics aging, we found significant
overlap in the age and irradiation treatment probesets, suggesting that irradiation damage
causes similar transcriptional changes as does the natural aging process. The smaller
number of genes that had a significant strain effect reflects the fact that only
approximately 1% of the genome is polymorphic between the background and congenic
mice. When 2-way ANOVAs (comparing B6 and congenic cells at young and old ages)
were performed, both pre- and post- irradiation treatment, chromosome 2 had the highest
number of differentially expressed probesets compared to all other chromosomes. We
also found that a large number of probesets located on chromosome 11 were
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differentially expressed. This may reflect the finding that a QTL regulating mouse
lifespan has been mapped to this chromosome (de Haan et al., 1999). An additional QTL
regulating the natural variation in lifespan between B6 and D2 mice was also mapped to
the same location on mouse chromosome 2 as the aging QTL, thus suggesting that genes
regulating aging and/or the DNA damage response may overlap with, be clustered with,
or influence those that affect lifespan. The fact that a total of 6,831 (15% of the total
45,101 probesets on the chip) probes were differentially expressed in the 3 way ANOVA
suggests that aging and irradiation, in addition to a small difference in strain, have a
profound effect on the transcriptional profiles of stem cells. Moreover, the presence of
differentially expressed genes located on chromosomes other than chromosome 2
suggests that genes in the QTL regulate the expression of genes located elsewhere in the
genome.
Candidate QT gene identification
Using the congenic mouse model, our search for candidate QT genes was greatly
facilitated by allowing us to first focus our attention on genes physically located within
the chromosome 2 QTL. I searched for candidate genes that may regulate the different
number of LSK cells in aged B6 and D2 mice by first identifying all significant
transcripts on the Affymetrix arrays that mapped to the critical congenic interval (130 Mb
- 150 Mb) on chromosome 2. From 2-way and 3-way ANOVAs a total of 90 genes
located within the chromosome 2 QTL were differentially expressed between the B6 and
congenic mice (Table 3.1). I then took advantage of the WebQTL database and searched
for genetic loci that are strongly linked to the variation in gene expression of all 90
individual differentially expressed transcripts present in the chromosome 2 QTL. The
WebQTL database contains information comparing the strain distribution pattern of
individual Affymetrix transcripts with the genetic distribution of B6 and D2 alleles at 779
markers located throughout the genome (Bystrykh et al., 2005). Performing this linkage
analysis allowed me to map cis and trans regions of the genome that regulate the
expression of the 90 transcripts located in the chromosome 2 congenic interval. Six
genes (Anapc1, Snrbp2, Rrbp1, Snx5, Rbl1, and Ndrg3) located in the interval were
found to be cis-regulated and were also differentially expressed between B6 and D2
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background strains according to other microarray experiments performed by our lab
(Table 3.2). Of the six genes, I chose to look more closely at sorting nexin 5 (Snx5) and
retinoblastoma like protein-1 (otherwise known as p107) due to their strong cis regulation
and because they had previously been linked to hematopoiesis and/or stem cell regulation
(Vanderluit et al., 2004; Vanderluit et al., 2007). Modifiers of Snx5 expression map to a
genomic interval spanning from 139.4 Mb to 154.3 Mb on chromosome 2 (significant
LRS linkage), a region containing D2Mit281 and D2Mit 282 (markers most tightly linked
to the trait) and Snx5 (Figure 3.3). Modifiers of p107 expression map to a genomic
interval spanning from 156.5 Mb to 157.1 Mb on chromosome 2 (suggestive LRS
linkage) containing p107 (Figure 3.4). Snx5 (144 Mb) is located upstream from p107
(156.8 Mb), thus there is a possibility that the genes to share a common promoter region
(Figure 3.5). However, this scenario is unlikely due to the large distance between the two
genes, as well as the fact that both genes have fairly large CpG islands in their 5-prime
regulatory regions.
According to the microarray analysis, B6 alleles up-regulate both Snx5 and p107
expression at both young and old ages compared to D2 alleles. I next used real time PCR
to confirm the differential expression of the genes in Lin- and LSK stem cell enriched
populations. Snx5 transcript levels were elevated in young and old B6 Lin- and LSK
cells compared to congenic cells (Figure 3.6 A and B). As expected, LSK cells from
DBA mice also express lower levels of Snx5 when compared to B6 cells. Similarly,
p107 transcript levels were elevated in young and old B6 Lin- cells compared to
congenics, but in LSK cells, p107 expression was significantly higher only in old B6 cells
(Figure 3.7 A and B). In young LSK cells, the inter-strain difference approached
significance (P = 0.06) but was not as pronounced. Again, old D2 LSK cells express
lower levels of p107 when compared to old B6 cells, and we found no significant
difference in p107 expression between old D2 and congenic LSK cells. Thus, these data
confirm the results obtained from the microarray analyses and suggest that Snx5 and
p107 are positive regulators of stem cell number. It is important to note that differential
Snx5 and p107 expression are apparent in young mice (this is true for both genes in Lincells and for Snx5 in LSK cells), but the phenotypic effects entrained by lifelong
differential expression do not become apparent until old age.

73

Discussion
Quantitative trait locus mapping studies have identified thousands of
chromosomal regions containing genes that affect a wide variety of complex phenotypes
ranging from alcoholism to diabetes and obesity. However, identifying individual QTL
genes has been slow and difficult over the past decade. Fortunately, five years ago when
I planned my dissertation project, new technologies such as the microarray, which
allowed for comparative genomics, and the publication of the mouse and human genomic
sequences set the stage for a new generation of QTL gene identification strategies. In my
studies, I used a combination of classical genetic linkage and microarray analyses to
identify Snx5 and p107 as novel regulators of HSC frequency in mice. Using microaray
technology, I found that Snx5 and p107 genes were differentially expressed between
young and old B6 and congenic Lin- cells. Quantitative real time PCR was used to
confirm these results in Lin- cells, as well as in more primitive LSK cells.
The use of the chromosome 2 congenic mouse model was pivotal in performing
this forward genetic approach to identify genes that regulate HSCs. The congenic mice
have a genome that is 99% B6 with the exception of the introgressed QTL interval from
D2 mice. The remaining 1% difference between the strains greatly reduced the number
of differentially expressed genes between D2 and B6 parental strains. A reciprocal
congenic model in which the QTL interval was introgressed from B6 mice onto a D2
genome was not available for these studies but would have further reduced the number of
potential candidate genes, assuming the genes were reciprocally regulated (i.e. a gene
would be upregulated in one congenic and down regulated in the reciprocal). Another
unique feature of the study is that cDNA amplification was not performed on any of the
samples used in the microarray. Because HSCs are such a rare cell type, other labs that
have performed gene expression studies with these cells relied on in vitro amplification
techniques (Ivanova et al., 2002; Ramalho-Santos et al., 2002). Amplification of cDNA
by a standard PCR procedure may result in the differential amplification of particular
transcripts, since sequences differ in the rate with which they can be amplified by PCR
(Lockhart and Winzeler, 2000). We obtained 500,000 Lin- cells from 5-10 mice for each
strain, age and treatment group, and three independent biological samples were
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hybridized to individual chips. Also, previous microarray studies relied on the use of
Affymetrix U74Av2 chips, which contain only 12,488 probesets located throughout the
mouse genome. In these studies, I used Affyterix M430 chips that contain 45,000
probesets, thus representing the entire mouse genome.
I used quantitative real time PCR to validate the differential expression of Snx5
and p107 in Lin- as well as in primitive LSK cells. Real time PCR is very sensitive, can
distinguish between closely related mRNAs, and yields results that are quantitative in
nature. Due to its relative ease and convenience of use, real time PCR is the preferred
method for validating microarray results compared to northern blotting and ribonuclease
protection assays, which require large amounts of RNA. Real time PCR confirmed that
B6 alleles up-regulate Snx5 and p107 expression in young and old Lin- cells. Because
Lin- cells contain a mixture of stem and progenitor cells, I also performed real time PCR
using LSK cells, which are highly enriched in stem cells. I found that Snx5 expression
was higher in young and old B6 LSK cells compared to congenic cells, whereas p107
expression was only increased in old B6 LSK cells. These results suggest that Snx5 and
p107 are positive regulators of stem cell number and may regulate the HSC aging trait.
The fact that B6 alleles increase the expression of Snx5 and p107 in young and old Lincells suggests that the rate of HSC aging may be due to lifelong differential expression of
the genes. Thus even though the genes are differentially expressed in young cells, the
resulting phenotypic effects do not become apparent until old age.
Due to the large number of cells required for Western blot analysis, it was not
possible to quantify protein levels of the genes in young and old Lin- or LSK cells. I did
however perform Western blots using whole bone marrow cells and found that the
differential expression patterns observed above were reproduced for Snx5 but not for
p107. Because primitive HSCs comprise only 0.01% of the total bone marrow
population, I was not surprised that I could not reproduce the expected expression
patterns for p107 and thus did not allow these results to prevent further investigation on
the role of this gene in hematopoiesis.
In order to determine the mechanisms that may contribute to the differential
expression of p107 and Snx5 between B6 and congenic HSCs, I analyzed the transcripts
for single nucleotide polymorphisms (SNPs) that exist between the two strains. The
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presence of polymorphisms in coding or regulatory elements of transcripts can have a
significant impact on gene expression levels as well as protein function, and thus can
potentially effect phenotypic variation in organisms. According to the Ensembl database
(www.ensembl.org) B6 and D2 alleles of p107 have four non-synonymous SNPs located
in coding regions as well as 16 intronic and seven 3’ untranslated region (UTR) SNPs
(Figure 3.5). The non-synonomous coding region SNPs are located in exons 9, 14, and
15. One SNP is located in region A of the pocket domain and two are located within the
spacer region of the pocket domain. The pocket domain consists of two conserved
sequences, A and B, which are separated by a spacer domain. This “pocket” is
responsible for mediating interactions with viral-oncoproteins as well as other cellular
proteins to carry out the biological function of this protein. Traditionally it is held that
the differential expression of a gene is caused by altered transcription factor binding due
to the presence of SNPs in regulatory regions (most notably 5’UTR promoter regions)
upstream of the gene. Although we did not detect any SNPs in the 5’ UTR region of
p107 emcompassing 800 base pairs upstream of the start codon, the exonic SNPs located
in the functional pocket domain of p107 have the potential to affect transcript stability,
which could result in the differential expression of the gene in a cellular context. Further,
although not yet studied, the presence of SNPs in the 3’ UTR of p107 could also affect its
expression. Indeed, Clop et al. identified a QTL on chromosome 2 that effects muscle
mass in sheep and showed that a point mutation in the 3’ UTR of the myostatin (GDF8)
gene (located in the QTL) created a target site for miRNAs. They then demonstrated that
differential miRNA binding to the transcript resulted in differential myostatin protein
expression (Clop et al., 2006). There are a total of 15 predicted murine microRNA
binding sites in the 3’ UTR of p107 as identified by PicTar WEB INTERFACE (Krek et
al., 2005). Benetti et al. recently showed that the p107-related protein, Rbl2 (p130), is
transcriptionally down-regulated by the mir290 cluster of miRNAs (Benetti et al., 2008).
It is therefore conceivable that the expression of other members of the retinoblastoma
family are regulated in a similar fashion.
In order to identify SNPs between B6 and congenic mice located in the Snx5
transcript, I again used the Ensembl database. I found that there are 8 3’UTR SNPs and 8
intronic SNPs between B6 and D2 mice in Snx5 (Figure 3.5). Although this gene does
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not have any SNPs located in its coding region, it is possible that some of the intronic
SNPs may modify Snx5 expression. Also, using the PicTar WEB INJTERFACE, I found
7 predicted murine microRNA binding sites in the 3’ UTR of Snx5, thus it’s possible that
SNPs located in the 3’ UTR may modulate Snx5 expression.
In order to identify cis- and trans-acting factors that affect the expression of p107
and Snx5, I used WebQTL software, which contains a quantitative gene expression
database in LSK stem cells of all BXD mouse strains. This database allows one to map
the regions of the genome that modify the expression of genes of interest (Bystrykh et al.,
2005). I found that both Snx5 and p107 are cis- regulated, meaning that modifiers of
their expression map very close to the actual gene itself. In addition, negative additive
effects indicate that B6 alleles increase the trait values (p107 and Snx5 expression),
which is consistent with the results obtained from microarray and real time-PCR
experiments. These results therefore suggest the existence of regulatory factors in the
proximal regions surrounding p107 and Snx5, and further support our hypothesis that
these genes are directly or indirectly responsible for the phenotypes conferred by the
chromosome 2 QTL.
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Young (2-4 mo.)

Old (24-25 mo.)

B6
No IR
2 Gy IR
Congenic

Figure 3.1 Microarray experimental design.
Schematic illustrating the experimental design of the microarray analysis. Using B6 and
congenic mice at young and old ages allows for the identification of both inter- and intrastrain changes in gene expression that accompany aging. We chose to use non-irradiated
as well as irradiated mice in order to test our surrogate assay to natural aging. A total of
24 arrays (3 for each strain, age, and treatment group) were used.
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Figure 3.2 Flow Chart of Microarray Data Analysis.
A total of 6,831 probe sets were found to be significant with a p-value of ≤ 0.01. The
probesets were further divided into three categories: 1) probesets significant for a 3-way
interaction, 2) probesets significant for a 2-way interaction, and 3) probesets significant
for a main effect.
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Table 3.1. Differentially expressed probesets between B6 and congenic
mice located within the chromosome 2 QTL
Probe Set ID
1450698_at
1427496_at
1444524_at
1449445_x_at
1458358_at
1453055_at
1424268_at
1446807_at
1418495_at
1419270_a_at
1437193_s_at
1434197_at
1421811_at
1416800_at
1438957_x_at
1448233_at
1434443_at
1451505_at
1426533_at
1428580_at
1448534_at
1435449_at
1452767_at
1426613_a_at
1419202_at
1433607_at
1448184_at
1451337_at
1422842_at
1419038_a_at
1426765_at
1441931_x_at
1417941_at
1431431_a_at
1417664_a_at
1416059_at
1424308_at
1434400_at
1423080_at
1423204_at
1428402_at
1417648_s_at
1417124_at
1418244_at
1425895_a_at
1428820_at
1449455_at
1417500_a_at
1448820_a_at
1420664_s_at
1422479_at
1448626_at
1455080_at

Gene Title
dual specificity phosphatase 2
expressed sequence AI851464
LOC433475
microfibrillar-associated protein 1
pantothenate kinase 2 (Hallervorden-Spatz syndrome)
sema domain, transmembrane domain (TM), and cytoplasmic
domain, (semaphorin) 6D
spermine oxidase
Ubiquitin specific protease 8
zinc finger CCCH type domain containing 8
deoxyuridine triphosphatase
small nuclear ribonucleoprotein B
attractin
thrombospondin 1
transient receptor potential cation channel, subfamily M,
member 7
CDP-diacylglycerol synthase (phosphatidate
cytidylyltransferase) 2
prion protein
Anaphase promoting complex subunit 1
coiled-coil-helix-coiled-coil-helix domain containing 5
nucleolar protein 5A
biliverdin reductase A
protein tyrosine phosphatase, non-receptor type substrate 1
BCL2-like 11 (apoptosis facilitator)
ribosome binding protein 1
U2 small nuclear ribonucleoprotein B
cystatin F (leukocystatin)
cerebellin 4 precursor protein
FK506 binding protein 1a
proteasome (prosome, macropain) inhibitor subunit 1
5'-3' exoribonuclease 2
casein kinase II, alpha 1 polypeptide
COMM domain containing 7
glutathione synthetase
haloacid dehalogenase-like hydrolase domain containing 4
nitrogen fixation gene 1 (S. cerevisiae)
N-myc downstream regulated gene 3
SEC23B (S. cerevisiae)
solute carrier family 24 (sodium/potassium/calcium
exchanger), member 3
TGFB-induced factor 2
translocase of outer mitochondrial membrane 20 homolog
(yeast)
transmembrane 9 superfamily protein member 4
zinc finger, CCHC domain containing 3
sorting nexin 5
destrin
N-acetyltransferase 5 (ARD1 homolog, S. cerevisiae)
inhibitor of DNA binding 1
microtubule-associated protein, RP/EB family, member 1
hemopoietic cell kinase
transglutaminase 2, C polypeptide
eukaryotic translation initiation factor 2, subunit 2 (beta)
protein C receptor, endothelial
acetyl-Coenzyme A synthetase 2 (ADP forming)
CDK5 regulatory subunit associated protein 1
protein phosphatase 1, regulatory (inhibitor) subunit 16B
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Chromosome

P-value
0.00035
0.00970
0.00035
0.00970
0.00101

2 F1
2 F1
2 F1
2 F1
2 F1|2 70.0 cM
2 F1|2 73.0 cM
2 F1|2 73.9 cM
2 F1-F3|2 65.0 cM

0.01041
0.00087
0.00428
0.00012
0.00072
0.00083
0.00576
0.00103

2 F2

0.00600

2 F2|2 73.0 cM
2 F2|2 75.0 cM
2 F3
2 F3
2 F3
2 F3|2 62.0 cM
2 F3|2 73.1 cM
2 F3-G1
2 G1
2 G1
2 G1-G3
2 G3
2 G3
2 G3
2 H1
2 H1
2 H1
2 H1
2 H1
2 H1
2 H1
2 H1

0.00093
0.00000
0.00038
0.00160
0.00015
0.00118
0.00052
0.00001
0.00009
0.00409
0.00083
0.00096
0.00085
0.00271
0.00088
0.00000
0.00001
0.00289
0.00019
0.00375
0.00600
0.00340

2 H1
2 H1

0.00550
0.01041

2 H1
2 H1
2 H1
2 H1|2 80.0 cM
2 H1|2 81.4 cM
2 H1|2 82.0 cM
2 H1|2 84.0 cM
2 H1|2 84.0 cM
2 H1|2 86.0 cM
2 H1|2 89.0 cM
2 H1|2 90.0 cM
2 H1-3
2 H2
2 H2
2 H2

0.00149
0.00039
0.00477
0.00000
0.00025
0.00110
0.00072
0.00013
0.00064
0.00000
0.00108
0.00464
0.00411
0.00077
0.00007

2 F1
2 F1
2 F1
2 F1
2 F1

1434438_at
1456867_x_at
1448582_at
1458039_at
1424161_at
1417068_a_at
1436015_s_at
1420054_s_at
1430388_a_at
1448345_at
1424511_at
1458501_at
1424411_at
1427844_a_at
1437414_at
1439802_at
1425349_a_at
1452428_a_at
1438957_x_at
1417947_at
1416985_at
1416174_at
1429328_at
1422488_at
1433826_at
1425166_at
1420631_a_at
1447898_s_at
1424767_at
1434069_at
1448847_at
1429947_a_at
1452954_at
1417976_at
1430288_x_at
1441923_s_at
1417786_a_at

SAM domain and HD domain, 1
serologically defined breast cancer antigen 84
catenin, beta like 1
Nuclear receptor coactivator 3
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27
protein tyrosine phosphatase, non-receptor type 1
serine/threonine kinase 4
solute carrier family 35, member C2
sulfatase 2
translocase of outer mitochondrial membrane 34
aurora kinase A
vesicle-associated membrane protein, associated protein B
and C
expressed sequence AI840826
CCAAT/enhancer binding protein (C/EBP), beta
zinc finger protein 217
Serine/threonine kinase 35 (Stk35), mRNA
myelin basic protein expression factor 2, repressor
beta-2 microglobulin
CDP-diacylglycerol synthase (phosphatidate
cytidylyltransferase) 2
proliferating cell nuclear antigen
protein tyrosine phosphatase, non-receptor type substrate 1
retinoblastoma binding protein 9
NSFL1 (p97) cofactor (p47)
NTF2-related export protein 1
TSPY-like 3
Retinoblastoma-like 1 (p107)
bladder cancer associated protein homolog (human)
splicing factor, arginine/serine-rich 6
cadherin 22
cDNA sequence BC067047
tumor differentially expressed 1
Z-DNA binding protein 1
ubiquitin-conjugating enzyme E2C
adenosine deaminase
ribosomal protein S21
endothelin 3
regulator of G-protein signaling 19
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2 H2
2 H2|2 92.0 cM
2 H2|2 94.0 cM
2 H2-H4
2 H3
2 H3
2 H3
2 H3
2 H3
2 H3
2 H3|2 100.0 cM

0.00524
0.00499
0.00249
0.00309
0.00017
0.00029
0.00371
0.00103
0.00519
0.00642
0.00953

2 H3|2 103.0 cM
2 H3|2 49.6 cM
2 H3|2 95.5 cM
2 H3|2 99.0 cM
chr2 F1
chr2 F1|2 73.0 cM
chr2 F1-F3|2 69.0 cM

0.00900
0.00220
0.00605
0.00138
0.00058
0.00058
0.00330

chr2 F2|2 73.0 cM
chr2 F2|2 75.0 cM
chr2 F3|2 73.1 cM
chr2 G1-H1
chr2 G3
chr2 H1
chr2 H1
chr2 H1
chr2 H1|2 88.0 cM
chr2 H2|2 79.8 cM
chr2 H3
chr2 H3
chr2 H3
chr2 H3
chr2 H3|2 93.0 cM
chr2 H3|2 94.0 cM
chr2 H4
chr2 H4|2 104.0 cM
chr2 H4|2 45.0 cM

0.00977
0.00000
0.00004
0.00107
0.00000
0.00730
0.00047
0.00003
0.00437
0.00636
0.00401
0.00007
0.00071
0.00000
0.00020
0.00000
0.00004
0.00137
0.00019

Table 3.2 Differentially expressed cis regulated genes in the chromosome 2 QTL
Probe ID

Gene Name

Gene
Symbol

Location
(Mb)

Function

Anaphase promoting complex 1

Anapc1

128.4 Mb

regulation of cell cycle

U2 small nuclear
ribonucleoprotein B

Snrbp2

142.8 Mb

nuclear mRNA splicing,
mRNA processing

ribosome binding protein 1

Rrbp1

143.7 Mb

protein targeting and transport

Sorting nexin 5

Snx5

144.0 Mb

intracellular signaling,
protein transport/trafficking

1425166_at

Retinoblastoma like protein 1

Rbl1

156.8 Mb

cell differentiation

1417663_a_at

N-myc downstream regulated
gene 3

Ndrg3

156.9 Mb

negative regulation cell cycle,
negative regulation of transcription

1434443_at
1426613_a_at

1452767_at

1417648_s_at

A total of six cis regulated genes located in the congenic interval were found to be
differentially expressed between young and old B6 and congenic mice as well as between
B6 and DBA mice. RNA isolated from B6 and chromosome 2 congenic Lin- cells was
labeled and hybridized to Affymetrix Mouse Genome 430 chips. Three independent
experiments from three treatment groups (strain, age, and irradiation treatment) were
used to quantify differential expression patterns.
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Chromosome 2
Significant
LRS Threshold

Figure 3.3 Cis-acting quantitative trait loci that modulate Snx5 expression.
Using WebQTL, we found a QTL on chromosome 2 that influences Snx5 expression.
The genomic interval spans from 139.4 Mb to 154.3 Mb on chromosome 2 and reaches
significant LRS threshold. The orange tick marks on the bottom of the figure represent
SNPs across chromosome 2. The area surrounding Snx5 is highly polymorphic between
B6 and DBA mice.
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Chromosome 2

Suggestive
LRS Threshold

Figure 3.4 Cis-acting quantitative trait loci that modulate p107 expression. Using
WebQTL, we found a QTL on chromosome 2 that influences p107 expression. The
genomic interval spans from 156.5 Mb to 157.16 Mb on chromosome 2 and reaches
suggestive LRS threshold. The orange tick marks on the bottom of the figure represent
SNPs across chromosome 2. Again, the area surrounding p107 is highly polymorphic
between B6 and DBA mice.
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Figure 3.5 Location of Snx5 and p107 within the congenic interval.
p107 and Snx5 are transcribed from the minus strand on chromosome 2. Shown here are
8 SNPs located within the 3’ regulatory region of Snx5 and seven SNPs in the 3’ UTR of
p107 as well as 4 non-synomous coding region SNPs.
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Figure 3.6 Differential expression of Snx5 mRNA in Lin- and LSK cells.
200,000 Lin- cells were sorted from young and old mice and mRNA levels were
measured by real time PCR. Snx5 mRNA levels are significantly higher in young and
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old B6 Lin- cells compared to congenic cells (P ≤ 0.01) (A). 100,000 LSK cells were
sorted from young and old animals and mRNA levels were measured by real time PCR.
Snx5 mRNA levels are significantly higher in young B6 LSK cells compared to congenic
cells (P≤ 0.01). I detected no significant difference in Snx5 expression in young DBA
cells compared to young B6 and congenic cells. Snx5 mRNA expression is significantly
higher in old B6 LSK cells compared to old congenic and old DBA LSK cells (P ≤ 0.05)
(B). Results are given as mean ± SEM (n ≥ 5 mice per experiment, 12 measurements
from 3 replicate experiments).
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Figure 3.7 Differential expression of p107 mRNA in different HSC compartments.
200,000 Lin- cells were sorted from young and old mice and mRNA levels were
measured by real time PCR. p107 mRNA levels are significantly higher in young and old
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B6 Lin- cells compared to congenic cells (P ≤ 0.01) (A). 100,000 LSK cells were sorted
from young and old animals and mRNA levels were measured by real time PCR. p107
mRNA levels are not significantly different between the three strains in young LSK cells.
However, p107 mRNA expression is significantly higher in old B6 LSK cells compared
to old congenic and DBA LSK cells (P ≤ 0.05) (B). Results are given as mean ± SEM (n
≥ 5 mice per experiment, 12 measurements from 3 replicate experiments).
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CHAPTER FOUR
Functional effect of retroviral overexpression of p107 and Snx5 in murine HSCs
Summary
In order to determine whether p107 and Snx5 expression influence HSC
frequency, I used retroviral vectors to overexpress both genes in congenic HSCs. I
constructed individual vectors containing p107 and Snx5 cDNA and transfected these as
well as an empty vector control into young congenic bone marrow cells. Using GFP to
identify transduced cells, p107, Snx5, and empty vector control cells were sorted using
flow cytometry and subsequently used for in vitro cobblestone area forming cell assays
CAFC). Upon performing CAFC assays, I showed that congenic HSCs overexpressing
p107 increased the frequency of day21, day28, and day35 CAFCs compared to cells
expressing the empty vector control. Similarly, congenic HSCs overexpressing Snx5
increased the frequency of day14, day21, and day35 CAFCs compared to cells expressing
the control vector. These results provide strong evidence that p107 and Snx5 are positive
regulators of HSC number and suggest that life-long elevated expression of the genes
(such as that seen in B6 HSCs) may protect the stem cell compartment and delay the
signs of aging in this vital cell population. Although not available at the time when the
dissertation was under preparation, functional CRU assays in which I measure the in vivo
frequency of congenic HSCs transduced with p107 or Snx5, are being performed to
investigate the role of each gene’s expression on HSC number. As HSC expansion
techniques have not proven very effective, the data presented here may be useful for the
development of new strategies to expand HSCs in the clinic.
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Introduction
The murine hematopoietic system is the best-characterized mammalian stem cell
model despite the fact that HSCs are inherently rare cells types. This is due in part to the
widespread use of gene transfer techniques in which the gene of interest is delivered into
target cells under the control of a retroviral promoter. Retroviral-mediated gene transfer
techniques have been used extensively in HSC biology, and have identified numerous
genes that are vital for the proliferation, differentiation and self-renewal of HSCs.
This methodology can be used to reconstitute a defective function or to analyze protein
function during hematopoiesis by overexpression. In my studies I employ the latter and
determine the effect of p107 and Snx5 overexpression on the number of HSCs in B6 and
congenic mice.
Retroviral vectors are appealing vehicles for gene transfer for several reasons: 1)
they stably integrate into host chromosomal DNA, 2) they deliver genes to target cells at
high efficiency and allow for long-term, stable expression of introduced genetic elements,
and 3) the retroviral promoter can direct high-level, efficient gene expression.
The main advantage of using retroviruses when manipulating hematopoietic cells is that
they integrate into the host genome and therefore are transmitted to progeny through cell
division. This ensures that the retrovirus construct remains present and continues to
express the gene of interest in differentiated progeny of HSCs that were originally
infected. In this regard, bone marrow cells can be harvested, manipulated in vitro, and
either be used for in vitro HSC assays or transplanted back into conditioned recipient
mice (where they will reconstitute the entire blood system of the recipient), thus making
it possible to study how the overexpression of a gene affects the entire hematopoietic
system.
In our lab, we use Phoenix helper-free retrovirus producer lines to package
retroviral particles. The Phoenix packaging cell lines were created by placing cell
constructs capable of producing gag-pol and envelope protein for ecotrophic and
amphotrophic viruses into the 293T cell line. The 293T cell line is an easily transfectable
human embryonic kidney line transformed with adenovirus E1a and carrying a
temperature-sensitive T antigen co-selected with neomycin (Graham et al., 1977).
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Packaging cells provide the structural and regulatory proteins required in trans for
assembling a viral particle. Retroviral vectors carry only cis elements necessary to
facilitate packaging, reverse transcription, and integration. This is important because
once transduced, the retroviral vector is unable to replicate.
Infection of HSCs by retroviral vectors is dependent on numerous factors, including
cycling status of the target cell population, the specific infection protocol used, and prestimulation of the cells to growth stimulatory factors before infection. It is vital to
preserve the functional qualities of HSCs during the period of in vitro manipulation since
down stream assays require intact functional capabilities of HSCs. In order to achieve
successful retroviral transduction, the target cells must be actively replicating at the time
of infection (Miller et al., 1990). Since HSCs are a relatively quiescent population, it is
necessary to pre-treat donor animals with 5-fluorouracil (5-FU), a cytotoxic drug that acts
as a pyrimidine antagonist. 5-FU functions to inhibit DNA synthesis both by blocking
the formation of normal pyrimidine nucleotides via enzyme inhibition and by interfering
with DNA synthesis after incorporation into a growing DNA molecule, thus it selectively
kills hematopoietic progenitor cells that are actively cycling while sparing the primitive
HSC population. In response to the elimination of progenitor cells, the HSCs begin to
cycle, thus allowing retroviral gene transfer studies to be performed in this cell
population. Additional studies with hematopoietic cells show that gene transfer efficiency
is improved when the HSCs are pre-stimulated with growth factors (Lim et al., 1989).
Particularly, pretreatment in vitro of donor cells from 5-FU treated mice with the
combination of interleukin 3 (IL-3), IL-6, and stem cell factor (SCF) greatly improves
gene transfer efficiency (Luskey et al., 1992). In my hands, I usually achieve 8-10%
infection efficiency of primary HSCs, thus even with enhanced transduction protocols, it
is still very difficult to obtain large numbers of transduced cells.
The efficiency of gene transfer varies considerably and not all target cells become
infected. This results in a mixed population of transduced and non-transduced cells,
therefore it is necessary to tag your vector with a selectable marker that allows for the
distinction between infected and non-infected cells. For my experiments, I used a
retroviral vector (Sfbeta 91) that contained green fluorescent protein (GFP) placed under
internal ribosome entry sequence (IRES) translation. The gene of interest and GFP are
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co-transcribed into a single mRNA encoding both genes from the same promoter. Protein
synthesis is achieved by cap driven translation of the first gene and IRES driven
translation from the second cistron (Haviernik et al., 2008). Cells that express the gene
will also express GFP, thus making it possible to isolate the cells of interest for use in
functional experiments. In my experiments, I individually cloned the coding sequences
of p107 and Snx5 into the Sfbeta 91 vector. Primary HSCs transduced with these vectors
were then used for in vitro CAFC experiments.
p107 is a member of the reintoblastoma (Rb) family of proteins, which include
pRb and p130 (Classon et al., 2000). pRb is the best known member of this pocket
protein family, and was the first tumor suppressor gene to be identified and cloned (Lee
et al., 1987; Sparkes et al., 1983). Members of the pRb family are structurally similar,
with greatest homology lying in a pocket domain that mediates interaction of the proteins
with the E2F family of transcription factors as well as with viral oncoproteins (Classon
and Dyson, 2001). Studies examining mice with targeted mutations in pRb genes suggest
that the three proteins have overlapping functions (Clarke et al., 1992; Jacks et al., 1992;
Lee et al., 1992; Lee et al., 1994), the most prominent of which is to regulate cell
proliferation by negatively regulating the activity of E2F transcription factors.
Hypophosphorylated pRb proteins bind to members of the E2F family of transcriptional
regulators and block E2F proteins from activating genes involved in cell cycle
progression (Nevins, 1992). However, unlike pRB, mutations in p107 and p130 are not
frequently observed in human cancers, thus suggesting that the proteins have at least
some non-redundant functions. Vanderluit et al. looked specifically at the role of p107 in
neural stem cells, and consistent with its role as a growth suppressor, found that it
negatively regulates the number of neural stem cells in both the developing and adult
brain (Vanderluit et al., 2004). Additional studies by Kondo et al. used a nonphosphorylatable and thus constitutively active p107 to demonstrate that it can inhibit S
phase progression a BaF3-derived mouse pro-B cell line (6-1 cells) (Kondo et al., 2001).
They also show that the exposure of cells to cisplatin, a DNA-damaging agent, causes S
phase arrest, which is associated with the accumulation of hypophosphorylated p107, and
thus conclude that p107 participates in inhibition of S phase progression in response to
DNA damage (Kondo et al., 2001). I hypothesize that overexpression of p107 in bone
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marrow cells exposed to irradiation (i.e. cellular stressor) will force them to arrest at G1,
thus allowing cells time to repair damage, enter a senescent state, or undergo apoptosis.
Over the lifetime of the animal, this intact cell cycle checkpoint would prevent DNA
damage accumulation in the stem cell compartment and thus would ensure long-term
function of the hematopoietic system. Several labs have studied the functional role of
pRB in the HSC compartment, but limited data exists on the role of p107 in
hematopoiesis (Daria et al., 2008; Spike et al., 2004; Spike and Macleod, 2005; Walkley
and Orkin, 2006). In order to determine the effect of p107 overexpression on the
regulation of HSC numbers, I constructed the aforementioned retroviral vector containing
p107 and overexpressed this gene in congenic bone marrow cells enriched in HSCs.
The other candidate gene uncovered in the microarray analysis, Snx5, is a
member of a large family of sorting nexin proteins that are involved in various aspects of
endocytosis and protein trafficking (Worby and Dixon, 2002). The Snx5 protein has
been reported to bind the Fanconi anemia complementation group A (FANCA) protein,
and increased expression of Snx5 in cells increases FANCA protein levels (Otsuki et al.,
1999). Eleven Fanconi anemia (FA) genes have been identified, and collectively the
proteins function to regulate how cells recognize and repair DNA damage (Mathew,
2006). It has been shown that FA genes are highly expressed in primitive hematopoietic
cells, suggesting the genes may be involved in maintenance of the stem cell pool and/or
differentiation (Aube et al., 2003). The Fanconi anemia syndrome is a rare recessive
genetic disorder characterized by chromosomal fragility, bone marrow failure, and
predisposition to cancer. The altered DNA repair and damage response phenotype of this
syndrome is shared by several accelerated aging syndromes including Bloom,Werner,
and ataxia telangiectasia (Zhang et al., 2007). I hypothesize that Snx5 controls cellular
levels of FANCA, thereby facilitating the cells ability to respond to and/or repair DNA
damage. Reduced levels of Snx5, and possibly FANCA, in aged congenic stem cells
(and young cells exposed to radiation) may dampen DNA response/repair pathways, thus
leading to senescence, cellular aging, and stem cell depletion.
In addition to binding the FANCA protein, Snx5 has also been shown to
translocate to the plasma membrane in response to Epidermal growth factor (EGF)
stimulation and inhibit EGF receptor (EGFR) degradation (Liu et al., 2006; Merino-Trigo
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et al., 2004). Recently it has been shown that EGFR is phosphorylated and activated
after cellular stressors such as irradiation (Dittmann et al., 2005). Upon activation,
EGFR translocates to the nucleus where it binds and activates DNA-dependent protein
kinase (DNA-PK), which mediates non-homologous end joining (NHED) to repair DNA
double strand breaks (Bandyopadhyay et al., 1998; Dittmann et al., 2005; Lin et al.,
2001). It is possible that increased Snx5 expression aids in the stabilization of EGFR,
which in turn results in enhanced DNA repair capacity in the face of damage. Thus,
decreased Snx5 expression in congenic HSCs may result in reduced DNA repair
efficiency, which explains why they are extremely sensitive to 2 Gy of irradiation.
In order to determine the effect of Snx5 overexpression on HSC number, I
constructed a second retroviral vector encoding Snx5 and overexpressed this gene in
congenic bone marrow cells enriched in HSCs. It was not possible to overexpress p107
and Snx5 in old congenic cells due to large number animals that this task would require.
It takes approximately 12 young mice to yield enough cells (2-4 x 106 cells) to be injected
into one recipient mouse. Since the experiments were performed in triplicate and
quadruplicate, it would require nearly 100 old congenic mice to perform these
experiments. I maintain an active congenic breeding colony in the DLAR at the
University of Kentucky, therefore making it possible for me to obtain enough young mice
for the completion of these studies.
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Materials and Methods
Animals
Young (2-4 months) C57BL/6 (B6) (Ptprcb [CD 45.2]) mice were purchased from the
National Institute of Aging (NIA) Aged Mouse Colony at Harlan Sprague Dawley
(Indianapolis, IN) and were used as recipients of GFP+ cells. The mice served as in vivo
“incubators” to expand infected cells for use in CAFC assays. Chromosome 2 congenic
mice were generated as described previously (Geiger et al., 2005). The congenic interval
spans 50 Mbp (130Mbp -180 Mbp) on the distal end of chromosome 2. All mice were
female and were housed in the Division of Laboratory Animal Resources (DLAR) at the
University of Kentucky Chandler Medical Center and were maintained under pathogenfree conditions according to NIH guidelines for animal welfare.
Retroviral vectors
The coding regions of the genes were subcloned into the multi-cloning site of the
retroviral vector Sfbeta 91. The Sfbeta 91 backbone served as a control. Sfebta 91
contained a myeloproliferative sarcoma virus (MSFV)-derived 5’ long terminal repeat
(LTR) and a spleen focus forming virus (SFFV)-derived 3’LTR. It also contained an
internal ribosome entry site (IRES) derived from the encephalomyocarditis virus which
ensured simultaneous translation of the gene insert and the enhanced green fluorescent
protein (GFP) reporter gene.

The gene cDNA sequence was cloned upstream of the

IRES in Sfbeta 91, to yield the recombinant the vectors, MSFV-p107-IRES-GFP-SFFV
(p107GFP+) and MSFV-Snx5-IRES-GFP-SFFV (Snx5/GFP+). The recombinant vectors
were transfected into Phoenix helper-free packaging cells using a calcium phosphate
precipitation method. Production of high-titer retrovirus was carried out according to
standard procedures in the Phoenix packaging cells.
Infection of primary bone marrow cells
Primary bone marrow cells were harvested as described above from young congenic mice
that had been injected intraperitoneally with 150 mg per kg of body weight of 5fluorouracil (5-FU) (Sigma-Aldrich) 4 days prior to harvest. Cells were then cultured
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over night in Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 10%
FBS, 1% penicillin/streptomycin, 50 ng/mL recombinant mouse stem cell factor (mSCF),
10 ng/mL mouse interleukin 6 (mIL-6), and 10 ng/ml mouse interleukin 3 (mIL-3) (R&D
Systems). Cells were subsequently harvested and placed onto transwell membranes
(Corning Incorporated Life Sciences) at a density of 2x106 cells per well. Viral
supernatants plus 50 ng/mL mSCF, 10 ng/mL mIL-6, 10 ng/mL mIL-3, and 4 ug/mL
polybrene were added to the cells. Fresh supernatant (plus cytokines and polybrene) was
added to the cells 4 times over a period of 48 hours. The infected cells were then
harvested and transplanted into sub-lethally irradiated (6 Gy) B6 mice at a dose of 2x1064x106 cells per mouse to repopulate the myeloablated tissues.
Isolation of GFP+ cells
Twelve weeks post transplant, mice injected with infected cells were euthanized by CO2
asphyxiation and the femora, tibiae, and humeri were removed to a Petri dish with Hanks
Balanced Salt Solution (HBSS, GIBCO) supplemented with 2% fetal bovine serum (FBS,
Invitrogen) (media). Humeri were used in order to isolate the maximum amount of bone
marrow from the mice. Bones were flushed with 4 mL media to obtain a single cell
suspension. Erythrocytes in the bone marrow were eliminated by hypotonic lysis and the
cells were washed with media. GFP+ (empty vector, p107/GFP+, Snx5/GFP+) cells were
sorted from bone marrow on a FACS Vantage cell sorter (Becton-Dickinson) and were
used for cobblestone area forming cell (CAFC) assays. Frequencies of CAFCs were
calculated using maximum likelihood analysis with L-Calc software (Stem Cell
Technologies). Frequencies equal one divided by the number of cells yielding 37%
negative wells.
CAFC Assay for functional analysis of retrovirally transduced cells
Equal numbers of GFP+ retrovirally transduced cells (empty vector, p107/GFP+,
Snx5/GFP+) were sorted from primary recipient mice 12 weeks after initial transplant.
The CAFC assay was carried out as described previously (de Haan et al., 1997; Geiger et
al., 2001) with slight modifications described below. FBMD-1 stromal cells were plated
in a 96-well tissue culture plate 7-10 days before the start of the assay to form a confluent
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layer. After 7-10 days, 20 replicate wells were seeded with GFP+ cells at cell doses of
81,000, 27, 000, 9000, 3000, 1000, or 333 cells per well. In circumstances where it was
not possible to sort enough cells for six dilutions, cells were seeded at doses of 27, 000,
9000, 3000, 1000, or 333 cells per well. The cell culture media contained IMDM
(GIBCO) plus 20% horse serum, 80 U/ml penicillin, 80 mg/ml streptomycin (Life
Technologies), and 0.1 mM each of B-mercaptoethanol and hydrocortisone (SigmaAldrich). Individual wells were screened at days 7, 14, 21, 28, and 35 for the presence
of a cobblestone area, defined as colonies of at least five non-refractile cells growing
beneath the stromal layer.
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Results
Over-expression of p107 in congenic cells
In order to assess whether the overexpression of p107 affects HSC numbers, I first
overexpressed the gene in young unmanipulated congenic mice . Vectors (empty vector
control/GFP+ and p107/GFP+) were transfected into Phoenix cells and viral supernatant
was harvested after 24 and 48 hours. Once the viral supernatant was obtained, bone
marrow cells were harvested from congenic mice that received 5-FU four days prior to
sacrifice. Bone marrow cells were placed on a transwell and the viral supernatant was
applied to the cells for 48 hours. New supernatant was added approximately every 12
hours, and after 48 hours the cells were injected into sub-lethally irradiated recipients
(Figure 4.1). Based on results obtained in neural stem cells, we hypothesized that overexpression of p107 would decrease stem cell numbers. However, since p107 has been
reported to regulate cell proliferation in response to stress (Kondo et al., 2001;
Voorhoeve et al., 1999), I hypothesized that overexpression of p107 in cells exposed to
radiation would cause the cells to undergo cell cycle exit, thus facilitating the repair of
DNA damage, and ultimately preserving the long-term function of the cells. Proper cell
cycle control and exit in the HSC compartment in times of stress and throughout the
lifespan of the animal would ensure preservation of the HSC pool and contribute to
decreased aging of this population in B6 mice. Thus, a subtle increase in p107
expression throughout the lifetime of an individual may help to preserve the primitive
HSC compartment. I first made sure that the sorted p107/GFP+ cells were in fact
overexpressing p107 compared to the empty vector control at both transcript and protein
levels. I found that p107 transcript and protein expression was higher in cells transduced
with p107/GFP+ compared to those transduced with the empty vector control (Figure
4.2). After verifying that the congenic cells overexpress p107 compared to empty vector
control cells, p107/GFP+ cells were sorted and used for in vitro CAFC assays. In this
assay, primitive stem cells migrate beneath a pre-extablished stromal layer and form
colonies (cobblestones) at various time-points over a period of a month or more.
Cobblestones are defined as a cluster of at least five non-refractive cells growing beneath
the stromal layer. The longer the latency for a cobblestone to appear, the more primitive
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in nature the cell. Thus the frequency of long term repopulating stem cells correlates
with the frequency of CAFC day35 cells whereas more committed progenitor cells
correspond to CAFC day21 and day28 cells (Figure 4.3). To our surprise, we observed a
statistically significant two-fold increase in the frequency of CAFC day35 cells in cells
overexpressing p107 (1.79 ± 0.31 per 100, 000 GFP+ cells) compared with cells that
expressed the empty vector control (0.8 ± 0.14 per 100, 000 GFP+ cells) (P = 0.001)
(Figure 4.4). We also observed a statistically significant increase in day21 (6.44 ± 0.75)
and day28 (2.93 ± 0.42) CAFCs in cells overexpressing p107 compared to those
overexpressing the empty vector control (3.82 ± 0.43 and 1.44 ± 0.20, respectively) (P ≤
0.001). The increase in CAFC frequency in progenitor (day21 and day28 CAFC) as well
as stem (day35 CAFC) cells, suggests that p107 plays an important role in regulating cell
proliferation throughout various stages of hematopoiesis.
Overexpression of Snx5 in congenic cells
Similar to experiments with p107, I first overexpressed Snx5 in young unmanipulated
congenic mice. According to microarray experiments and RT-PCR, Snx5 expression is
elevated in old B6 stem cells compared to old congenic cells. Since old B6 mice have
higher numbers of HSCs compared to old congenic mice, I hypothesized that the
overexpression of Snx5 in congenic cells would increase HSC frequency in these mice.
Vectors (empty vector control/GFP+ and Snx5/GFP+) were transfected into Phoenix cells
and viral supernatant was harvested after 24 and 48 hours. Viral supernatant was added
to bone marrow cells harvested from congenic mice that received 5-FU four days prior to
sacrifice. The bone marrow cells were placed on a transwell and the viral supernatant
was applied to the cells for 48 hours and new supernatant was added approximately every
12 hours. Finally, infected cells were injected into sub-lethally irradiated mice, which
served as in vivo “incubators” to expand the GFP+ cell population. After 12 weeks, the
recipient mice were sacrificed and GFP+ cells (empty vector control and Snx5/GFP+)
were sorted and used for the in vitro CAFC assay. A period of 12 weeks post transplant
allows time for the establishment of stem and progenitor cell populations in vivo. After
this length of time, donor contributions to all hematopoitic compartments is maximized
and derived from stem cells originally present in the donor marrow. Before performing
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CAFC assays, I first measured Snx5 mRNA and protein levels in sorted empty vector
control/GFP+ and Snx5/GFP+ cells. I found that Snx5 mRNA and protein expression
were higher in Snx5/GFP+ cells compared to the control vector (Figure 4.5) and
proceeded to perform CAFC assays. In agreement with my hypothesis, I found a
significant increase in the frequency of day35 CAFCs in cells overexpressing Snx5 (1.17
± 0.13 per 100,000 GFP+ cells) compared to cells expressing the empty vector (0.77 ±
0.13 per 100,000 GFP+ cells) (P ≤ 0.05) (Figure 4.5). I also observed a significant
increase in the number of day14 (20.8 ± 2.07) and day21 (5.26 ± 0.50) CAFCs in cells
overexpressing Snx5 compared to cells expressing the empty vector (13.59 ± 1.91 and
3.86 ± 0.39, respectively) (P ≤ 0.05) (Figure 4.6). The fact that I did not detect a
difference in the number of day28 CAFCs can probably be explained by the fact that the
cumulative results are from 4 individual experiments, two of which involved sorting
Snx5/GFP+ cells and empty vector control/GFP+ cells on separate days. It is best to sort
the test gene cells and the control cells on the same day so that they are exposed to the
exact same stromal cell layers and so that they can be counted on the same day.
However, due to flow cytometer sorting schedules and time constraints this was not
always possible, and thus likely influenced the CAFC results when the experiments were
combined. For the two experiments in which Snx5/GFP+ and empty vector
control/GFP+ cells were sorted together, I observed a significant increase in day14,
day21, day28, and day35 CAFCs in cells overexpressing Snx5 compared to those
overexpressing the empty vector. Thus it is likely that Snx5 increases cell number
exclusively in stem and progenitor populations, but not in committed cell types, such as
day7 CAFCs.
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Discussion
Upon confirming the differential expression of p107 and Snx5 between young and
old B6 and congenic Lin- and LSK cells, I next used recombinant retroviruses containing
p107 and Snx5 cDNA to overexpress the genes in congenic bone marrow cells to further
validate the genes as candidate regulators of HSC aging and/or sensitivity to irradiation.
It must be noted that the radiation sensitivity phenotype was discovered serendipitously,
thus the gene(s) that regulates this trait may or may not be the same gene(s) that regulates
the stem cell aging phenotype. Upon performing in vitro CAFC experiments, I
demonstrated that p107 and Snx5 do in fact regulate the number of HSCs in chromosome
2 congenic mice. I found that the individual overexpression of p107 and Snx5 in young
congenic bone marrow cells resulted in a statistically significant increase in the number
of day35 CAFC cells compared to cells overexpressing the control vector. These
findings provide strong evidence that p107 and Snx5 positively regulate HSC number and
suggest that elevated expression of these genes in HSCs throughout the lifespan of mice
may affect the rate at which their HSCs age as well as affect HSC sensitivity to cellular
stressors. For these experiments I singly overexpressed p107 and Snx5 in congenic bone
marrow cells. It will be interesting in future experiments to determine if the dual
overexpression of p107 and Snx5 in the same cells leads to a further increase in stem cell
number compared to the present studies where the genes were individually expressed.
Additionally, although the data is not available at the time of dissertation writing, I am
performing CRU assays in vivo in which graded doses of donor Snx5 and p107
overexpressing cells are injected into lethally irradiated, but genetically distinguishable,
recipient mice along with a set number of competitor cells. These experiments will allow
me to calculate the absolute frequency of Snx5 and p107 overexpressing cells compared
to cells expressing the empty vector in recipient mice, and thus will undoubtedly reveal
whether the genes regulate HSC number in an in vivo setting.
Because HSCs are extremely rare, it is not possible to obtain them in sufficient
numbers for classical biochemical characterization. Therefore, in order to facilitate
functional studies of the hematopoietic system, retroviral gene transfer techniques serve
as useful tools. Enhanced gene transfer techniques such as pre-treatment of donor
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animals with 5-FU, the use of cytokines, and the use of selectable markers that allow for
the distinction between transduced and non-transduced cells have greatly improved the
efficiency of this technique in HSCs. Treatment of donor animals with 5-FU prior to
bone marrow harvest forces primitive cells into cycle and thus facilitates retroviral gene
transfer into HSCs. Additionally, pre-stimulation of donor marrow cells from 5-FU
treated mice with IL-3, IL-6, and SCF further enhances gene transfer into HSCs. Studies
have shown that SCF synergizes with other cytokines to promote the survival of primitive
cells during in vitro manipulations associated with retroviral infection (Luskey et al.,
1992). Even though the use of these techniques enhances retroviral gene transfer into
HSCs, the efficiency of gene transfer is never 100% and thus it is necessary to have a
way to assess infection efficiency in HSCs. In my studies, GFP served as a selectable
marker to track transduced cells which were then isolated by flow cytometry and used in
subsequent CAFC functional assays.
In the present study, I overexpressed p107 in primary congenic hematopoietic
bone marrow cells and performed in vitro CAFC assays to assess the role of p107 in
regulating HSC numbers. Surprisingly, I found that the overexpression of p107 resulted
in a significant increase in the frequency of CAFC day21, day28, and day35 cells
compared to empty vector controls. Based on studies performed by Vanderluit et al., I
expected to see a decrease in the frequency of CAFC day35 cells, especially since the
cells used in the assay had not been exposed to any overt replicative stress. I originally
hypothesized that overexpression of p107 in bone marrow cells exposed to irradiation
(i.e. cellular stressor) would force them to arrest at G1, thus allowing cells time to repair
damage, enter a senescent state, or undergo apoptosis. Over the lifetime of the animal,
this intact cell cycle checkpoint would prevent DNA damage accumulation in the stem
cell compartment and thus would ensure long-term function of the hematopoietic system.
In contrast, congenic cells may proceed through the cell cycle, thus resulting in the
accumulation of DNA damage in the congenic HSC pool. The accretion of damaged
cells may ultimately result in impaired function of congenic HSCs in old mice (Figure
4.6).
Daria et al. recently investigated the function of pRb in hematopoiesis by creating
an animal model in which floxed pRb alleles were deleted in the hematopoietic
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compartment by Cre recombinase driven by the Vav1 promoter (Daria et al., 2008). In
the absensce of pRB there was a significant decrease in the frequency of CAFC day35
cells. They went on to perform competitive transplant experiments with Vav-Cre Rb KO
cells, and observed a 8-fold reduced contribution to chimerism in peripheral blood
compared with control cells. Since they found identical numbers of HPCs and HSCs in
Vav-Cre Rb KO bone marrow and control bone marrow, they reasoned that pRb was a
regulator of hematopoietic stem and progenitor cells under conditions of stress, such as
transplantation and 5-FU treatment. Based on our observations with p107 in
hematopoietic cells, we propose that the cell sorting procedure and the CAFC assay itself
may serve as efficient stressors to trigger retinoblastoma family protein-mediated cell
cycle exit and arrest. Indeed, it is well established that primitive HSCs in the bone
marrow reside in a hypoxic microenvironment and that low oxygen levels play a role in
the maintenance of normal stem cell function (Cipolleschi et al., 1993; Danet et al., 2003;
Parmar et al., 2007). The CAFC assay was performed in 5% humidified incubators in
normoxic conditions (20% O2), whereas in vivo HSCs are maintained in hypoxic (< 3%
O2) conditions. This oxygen imbalance likely imparts additional stress on primitive
HSCs.
To my knowledge, extensive analysis of the function of the closely related pRb
gene, p107, has never been performed in the HSC compartment. LeCouter et al. did
however report a myeloproliferative disorder as well as extensive extramedullary
hematopoiesis in the spleen and liver (which was predominantly myeloid in composition)
in germ line mutated p107-/- BALB/cJ mice (LeCouter et al., 1998). They also observed
increased numbers of myeloid progenitor cells in the femurs of p107-/- mice, consistent
with results of Daria et al. (Daria et al., 2008). Although LeCouter et al. reported a less
severe phenotype when p107-/- mice were backcrossed to a B6 background, they did not
look closely at individual organ systems and certainly did not assess the phenotype in
response to conditions of stress. I propose that in addition to pRB, p107 plays an
important role in regulating HSCs. I further hypothesize that hematopoietic stem cells
are very sensitive to situations in which they are removed from their natural environment
and p107 may play a role in sensing this stress. Perhaps this is a protective mechanism
that HSCs have acquired in order to preserve the function and integrity of this vital cell
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population. Further, the elevated expression of p107 in B6 LSK cells may serve to protect
these cells from the damaging effects of low dose irradiation. The cells elicit proper cell
cycle checkpoints and are able to preserve the integrity of their population over time.
Cogenic LSK cells, on the other hand, may continue to cycle and therefore accumulate
cells with damaged DNA. Ultimately this scenario may result in impaired self-renewal
capacity and diminished numbers of HSCs over the life span of an organism.
Numerous studies have assessed the role of the closely related protein, pRB, in
the hematopoietic compartment (Daria et al., 2008; Lee et al., 1992; Spike et al., 2004;
Spike and Macleod, 2005). Spike et al. demonstrated cell intrinsic defective erythroid
maturation under stress conditions in Rb-/- cells as well as the loss of hematopoietic stem
and progenitor cells from the bone marrow and spleen of mice transplanted with Rb-/fetal liver cells. An additional study conducted by Spike et al., showed that Rb null
erythroblasts contained increased levels of reactive oxygen species (ROS), greater levels
DNA damage, as well as altered chromosome structure compared to wild-type cells
(Spike and Macleod, 2005). These data suggests that the Rb, and perhaps additional
pocket protein members, is required for hematopoietic homeostasis. Moreover, my
studies with p107 suggest that increased levels of these proteins may increase stem cell
number, although the mechanism of this function is not yet known. I am currently
performing an extensive in vivo analysis of the role of p107 in the HSC compartment.
CRU experiments with cells overexpressing p107 are being conducted in order to
determine if elevated expression of the gene corrects the early stem cell aging phenotype
observed in D2 and congenic mice.
The fact that p107 contains four SNPs resulting in amino acid substitutions
provides additional strength supporting our hypothesis that p107 is a QT gene that
regulates HSC aging because the exonic SNPs may explain differential p107 expresssion
in B6 and congenic mice. Rb family members contain a common region know as a
“pocket” which consists of two conserved domains, A and B, and a non-conserved spacer
region (Chow et al., 1996).

Starostik et al. have shown that the central pocket in p107,

including domains A and B, but not the spacer region, is sufficient for p107 to act as a
general cellular repressor as well as its ability to inactivate E2F (Starostik et al., 1996).
Additional studies have shown that the spacer region in p107 mediates an interaction with
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the cell cycle regulatory protein cyclin A, thus providing p107 with dual interaction
domains (Ewen et al., 1992; Faha et al., 1992; Smith and Nevins, 1995; Zhu et al., 1995).
Mutations in these regions critical for p107 function, although not causing differential
expression of the gene, could interfere with the normal functioning of the protein and
thus render cells more vulnerable to cellular stressors.
Snx5, the other candidate gene in these studies, has been shown to bind to the
FANCA protein and its knock down in zebrafish was shown to lead to an 80% reduction
in circulating blood cell production, thus making it an attractive potential regulator of
HSC function. Similar to studies performed with p107, I overexpressed Snx5 in congenic
bone marrow cells and performed in vitro CAFC assays to determine whether Snx5
affected the frequency of HSCs. According to microarray, real time PCR and western
blot data, Snx5 expression is elevated in young and old B6 HSCs compared to young and
old congenic HSCs. Because the number of primitive HSCs increases in B6 mice as they
age, I hypothesized that Snx5 was a positive regulator of HSC number and that its
overexpression in congenic bone marrow cells would increase HSC frequency. Upon
performing CAFC assays, I found a significant increase in the frequency of day14, day21,
and day35 CAFCs in congenic HSCs overexpressing Snx5 compared to cells expressing
the control vector. As explained previously, the reason I did not see an increase in the
number of day28 CAFCs in cells overexpressing Snx5 is likely due to the fact that in two
of the replicate assays, Snx5 overexpressing cells and empty vector control cells were not
isolated on the same day. This added technical variability to these studies, which could
have been avoided if the test cells were sorted at the same time. In two of the four
individual CAFC experiments, Snx5/GFP+ and empty vector control/GFP+ cells were
sorted on the same day. Upon combining these data, I observed a significant increase in
day14, day21, day28, and day35 CAFCs in cells overexpressing Snx5 compared to those
overexpressing the empty vector. These data suggest that elevated Snx5 expression
affects HSC frequency specifically in stem and progenitor cells and not in differentiated
cells and thus further validates our hypothesis that Snx5 may regulate the HSC aging
trait.
The CAFC results reinforce our hypothesis that overexpression of Snx5 increases
HSC number and suggest that the life-long elevated expression of Snx5 in B6 HSCs may
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help the cells respond to and repair DNA damage more efficiently than congenic HSCs.
This enhanced DNA repair capacity, possibly due to Snx5’s interaction with FANCA
and/or EGFR, may slow the aging of the cells and possibly increase their self-renewal
capacity which leads to an increase in HSC number with advancing age (Figure 4.7).
Unlike p107, Snx5 does not have any non-synomous coding region SNPs between
B6 and D2 mice. According the Ensembl genome browser, the gene does however have
8 3’UTR and 8 intronic SNPs. It is possible that the intronic SNPs could affect transcript
stability of thus expression of Snx5 mRNA. Also, due to the presence of 7 predicted
murine microRNA binding sites in the 3’ UTR of Snx5, it is possible that SNPs located in
the 3’ UTR may modulate Snx5 expression.
The fact that Snx5 has been shown to interact with two proteins that are
involved in mediating DNA repair processes is intriguing. The overexpression of Snx5 in
293 cells was shown to increase levels of the FANCA protein in a dose dependent
manner (Otsuki et al., 1999). Similarly, upon overexpressing Snx5 in a NR6/EGFR cell
line, EGFR expression was induced and maintained thus suggesting reduced degradation
of the receptor during EGFR signaling (Liu et al., 2006). As mentioned previously,
FANCA is one of eleven Fanconi anemia genes that collectively function to regulate how
cells recognize and repair DNA damage (Mathew, 2006). Cells (such as B6 HSCs) that
express high levels of Snx5 may also express high levels of FANCA, thus increasing the
DNA repair capacity and enhancing the longevity of these cells. Like FANCA, EGFR
has also been implicated in DNA repair pathways. EGFR is a cell surface receptor that
mediates cell proliferation, migration and survival. EGFR is frequently expressed in
cancers of epithelial origin, and its expression and activity correlate with tumor resistance
to radiotherapy (Chen and Nirodi, 2007). Recent studies show that EGFR plays a
radioprotective role which involves translocating to the nucleus and binding to and
activating DNA-PK, which then mediates NHEJ to repair DNA double stranded breaks
(Bandyopadhyay et al., 1998; Dittmann et al., 2005; Lin et al., 2001). Since Snx5 has
been shown to stabilize and prevent the degradation of EGFR, it is possible that increased
Snx5 expression enhances DNA repair capacity through the NHEJ repair pathway as
well. Snx5 may be working through both the FANC and the DNA-PK/NHEJ DNA repair
pathways to help protect the accumulation of damage in B6 HSCs. Reduced expression
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of Snx5 in congenic HSCs throughout the lifespan of the animal may reduce the ability of
the cells to respond to and repair DNA damage, which ultimately leads to a qualitative
and quantitative decline the in their hematopoietic system with age.
In summary, I have identified p107 and Snx5 as quantitative trait genes that
regulate the number of HSCs in B6 and congenic mice. CAFC assays confirmed that
increased expression of both genes increases HSC number in an in vitro setting.
Although the increased expression of both Snx5 and p107 resulted in small increases in
HSC number, the changes are biologically significant given the extensive proliferative
potential of primitive stem cells. Extemely small fluctuations in the size of the HSC pool
can result in dramatic differences in mature blood cell production, and thus immune
function, due to the fact that HSCs are the sole source of all differentiated blood cells.
In vivo CRU assays will be performed in future experiments to unequivocally
demonstrate that these genes regulate HSC numbers. I hypothesize that long term
elevated expression of the genes protects the HSC pool and thus ultimately slows the
aging of the cells and possibly the entire individual.
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Figure 4.1 Schematic illustrating the experimental design used for retroviral
transduction of HSCs. The Sfbeta 91 retroviral vector served as the backbone for p107
and Snx5 cDNA-containing vectors as well as an empty vector control. Phoenix
packaging cells were transfected with the vectors and high titer viral supernatant was
collected after 24 and 48 hours. Bone marrow cells were harvested from young congenic
mice that had been injected intraperitoneally with 150 mg per kg of body weight of 5-FU
4 days prior to harvest. The bone marrow cells were placed on a transwell insert (in a six
well plate) and were exposed to the viral supernatant for 2 days. Infected cells were then
injected into sub-lethally irradiated B6 recipient mice. Twelve weeks post
transplantation, GFP+ cells were sorted and used for in vitro CAFC assays.
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Figure 4.2 Overexpression of p107 in transduced HSCs. Real time PCR data showing
that p107 mRNA levels are elevated in primary GFP+ cells compared to cells infected
with the empty vector control (P ≤ 0.01) Results are given as mean ± SEM, n = 8
measurements from 2 individual experiments. Representative western blot showing
overexpression of p107 protein in sorted GFP+ bone marrow cells (B).
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Figure 4.3 Diagram of the cobblestone area forming cell (CAFC) assay.
The CAFC assay is in an in-vitro limiting dilution assay to measure HSC number. Stem
and progenitor cells of a particular developmental stage migrate beneath a stromal cell
layer and form cobblestone-like colonies. Cobblestone formation is assessed at various
days after plating and the maximum likelihood analysis is used to determine stem cell
number. The longer the latency before a cell proliferates and forms a cobblestone area,
the more primitive in nature the cell.
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Figure 4.4 CAFC numbers in congenic cells overexpressing p107 and the empty
vector control. I observed a statistically significant two-fold increase in the frequency of
day35 CAFCs in cells overexpressing p107 compared with cells that expressed the empty
vector as well as a significant increase in day21 and day28 CAFCs in cells
overexpressing p107 compared to those overexpressing the empty vector control (P ≤
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0.001) (A). Closer view of day 21, day 28, and day 35 CAFC numbers in young
congenic bone marrow cells overexpressing p107 or empty vector control (B). Results are
given as mean ± SEM, n = 4 replicate experiments.
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Figure 4.5 Overexpression of Snx5 in transduced HSCs. Real time PCR data showing
that Snx5 mRNA levels are elevated in primary GFP+ cells compared to cells infected
with the empty vector control (P ≤ 0.01) Results are given as mean ± SEM, n = 12
measurements from 3 individual experiments (A). Representative western blot showing
overexpression of Snx5 protein in sorted GFP+ bone marrow cells (B).
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Figure 4.6 CAFC numbers in congenic cells overexpressing Snx5 and the empty
vector control. I observed a statistically significant increase in the number of day14,
day21 and day35 CAFCs in cells overexpressing Snx5 compared to those overexpressing
the empty vector conrol (P ≤ 0.05) (A). Closer view of day21, day28 and day35 CAFC
numbers in congenic cells overexpressing Snx5 and the empty vector (B). Results are
given as mean ± SEM, n = 4 replicate experiments.
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Figure 4.7 Mechanism by which p107 may regulate HSC number
B6 bone marrow cells, which express high levels of p107, may undergo cell cycle arrest
after exposure to irradiation, thus allowing cells time to repair damage, enter a senescent
state, or undergo apoptosis. Over the lifetime of the animal, this intact cell cycle
checkpoint would prevent DNA damage accumulation in the B6 stem cell compartment.
In contrast, the congenic cells, which express low levels of p107, may proceed through
the cell cycle after the insult, thus resulting in the accumulation of DNA damage in the
congenic HSC pool. The accretion of damaged cells may ultimately result in impaired
function of congenic HSCs in old mice.
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Figure 4.8 Mechanisms by which Snx5 may regulate stem cell number.
Snx5 interacts with both FANCA and EGFR, two genes involved in DNA repair
pathways. Snx5 may serve to increase or stabilize FANCA and EGFR expression,
thereby facilitating enhanced DNA repair capacity in stem cells. Enhanced DNA repair
capacity throughout the lifespan of an organism may protect HSCs from accumulating
DNA damage and thus slow the aging process in these cells.

Copyright © Erin J. Oakley 2008
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CHAPTER FIVE
General Discussion and Conclusions
Despite their ability to self-renew and maintain essentially normal levels of
hematopoietic function throughout the lifetime of an organism, it has become
increasingly evident that hematopoietic stem cells (HSCs) are subject to qualitative and
quantitative changes and that these changes may affect both the rate of aging and
longevity of organisms. The main goal of my dissertation study was to evaluate the
hypothesis that one or more genes located in a QTL on murine chromosome 2 contributes
to the strain specific difference in the frequency of HSCs in aged C57BL/6 (B6) and
DBA/2 (D2) mice. However, in a broader sense, the ultimate goal of my research was to
identify genes in a murine mouse model that could one day be extended to human HSCs,
thus contributing to the understanding of the complex biology of HSC aging.
Following a classical forward genetic approach, I proposed three specific aims to
explore the aforementioned hypothesis: 1) to better understand the mechanistic basis for
the different number of HSCs in aged B6 and congeic mice by determining the cell cycle,
apoptotic, and self-renewal status of HSCs using a surrogate assay to mimic aging; 2) to
identify differentially expressed genes between B6 and congenic mice that may
contribute to the HSC aging phenotype using microarray technology; 3) to overexpress
candidate gene(s) uncovered in the microarray analysis and determine their effect on
HSC number and function.
Novel findings in this dissertation include the discovery that D2 alleles in the
chromosome 2 QTL affect the level of apoptosis and the self-renewal capacity of HSCs.
Specifically, D2 alleles decreased the percentage of lineage negative (Lin-) cells
undergoing apoptosis following 2 Gy of irradiation and drastically decreased the selfrenewal capacity of HSCs exposed to 2 Gy of irradiation as revealed by serial
transplantation experiments. In addition, microarray studies identified two novel
candidate genes that may regulate HSC aging, Retinoblastoma like protein 1 (p107) and
Sorting nexin 5 (Snx5). B6 alleles are associated with upregulated p107 and Snx5
expression as well as increased HSC number in aged mice, therefore I hypothesized that
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both genes are positive regulators of HSC number. Further, cobblestone area forming
cell assays (CAFC) revealed that p107 as well as Snx5 increased the frequency of day35
CAFCs, which correspond to primitive HSCs. Therefore these studies not only reveal the
power of combining classic QTL studies with modern microarray technologies to identify
genes underlying complex quantitative traits, but also provide strong evidence that p107
and Snx5 may regulate some aspect of HSC aging.
Unfortunately these studies cannot definitely determine whether p107 and Snx5
control the HSC aging phenotype or the sensitivity to low dose irradiation. It is possible
that the genes control both of the traits and that our surrogate assay to measure aging
activates the same molecular pathways that are at work in aged stem cell populations.
Indeed, my microarray studies showed significant overlap in the age and irradiation
treatment probesets, suggesting that irradiation damage causes similar transcriptional
changes as does the natural aging process. I am in the process of expanding my aged
congenic colony, and future experiments will be performed in which p107 and Snx5 will
be overexpressed in aged congenic cells. If I obtain similar results as observed in young
congenic cells, I will conclude that the genes do in fact regulate the number of HSCs in
old mice. In addition, performing self-renewal assays with old B6 and congenic cells will
allow for me to determine whether on not increased self-renewal capacity is the
mechanism by which B6 HSCs increase in number with age. Also, performing CAFC
experiments with transduced congenic cells that have been irradiated will determine
whether the genes affect HSC response to cellular stressors. Nonetheless, these current
studies do in fact indicate that elevated expression of p107 and Snx5 increase the number
of day35 CAFC numbers, which correspond to primitive stem cells.
In light of recent data suggesting that DNA damage accumulation throughout the
long lifespan of HSCs contributes to their decline in cellular function with age, the fact
that p107 and Snx5 may regulate the response to and/or the repair of DNA damage makes
them great candidates for regulating the complex biology of HSC aging. p107
participates in mediating cell cycle arrest in response to stress, which in turn allows cells
time to repair damage and proceed through the cell cycle or alternatively, undergo
apoptosis. Indeed, p107 may help prevent the accumulation of DNA damage in HSCs,
therefore preserving their function in old age. Moreover, the mechanistic phenotypes of
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the congenic cells, including reduced apoptosis in Lin- cells and a subtle but nonsignificant increase in LSK cell cycling may result from the decreased expression of p107
in these mice. Reduced levels of p107 expression are consistent with increased cycling
as well as the inability to exit cycle and undergo apoptosis in response to DNA damage in
the form of irradiation. Like p107, Snx5 may also be involved, through FANCA or
EGFR, in the regulation of HSC response to and repair of DNA damage, and thus may
prevent the accumulation of DNA damage in HSCs. Reduced levels of Snx5 in congenic
HSCs may compromise their ability to repair DNA damage, which may contribute to the
profound decrease in self-renewal capacity of these cells in response to irradiation. To
my knowledge there is no available data linking the cellular pathways of p107 and Snx5,
however it is possible that the two genes work in the same pathway to regulate HSC
number. The underlying mechanisms by which p107 and Snx5 control HSC pool size
must be resolved in order to determine whether the genes may act together to effect stem
cell number.
In conclusion, although the clinical applications of these findings may be far
away, my studies have identified two novel regulators of HSC number and thus bring us
one step closer toward understanding the genes and molecular pathways that regulate
stem cell number as well as stem cell aging and response to stress. However, as
mentioned previously, more experiments need to be performed in order to determine the
exact context in which p107 and Snx5 regulate HSC number. In addition to the
aforementioned experiments, I will examine the effects of the knock-down of p107 and
Snx5 using morpholino technology to help validate them as candidate genes. I
hypothesize that performing CAFC assays with cells in which p107 and Snx5 have been
knocked-down will decrease the frequency of day35 CAFCs. Ultimately, I would like to
expand these findings to human HSC biology in order to determine whether the
expression of p107 and Snx5 regulate human stem cells. Hopefully, these studies will aid
in the development of HSC amplification strategies, which will expand the use of these
cells in transplantation procedures for the treatment of hematological diseases. For
example, the overexpression of p107 and Snx5 may be able to expand a cancer patient’s
normal HSCs for use in autologous stem cell transplants. Overexression of the genes in
normal stem cells may be able to increase the number of the patient’s HSCs which could
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then be reintroduced to the patient after high dose chemotherapy and/or radiation
treatment. The reintroduced cells would function to restore or rescue hematologic and
immunologic function following high dose therapy. This procedure would not only
reduce the number of cells necessary for the initial harvest, but would also eliminate the
need to locate allogenic donors which are often difficult to find. Stem cell therapies to
treat various cancers have advanced greatly in past several years. It is my hope that the
research performed in this dissertation will aid in the advancement and use of such
therapies.

Copyright © Erin J. Oakley 2008
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